Jackson Financial Inc. 10-Q

Item 1. Financial Statements . Jackson Financial Inc. Condensed Consolidated Balance Sheets (in millions, except share data) March 31, December 31, 2026 2025 Assets (Unaudited) Investments: Debt Securities, available-for-sale, net of allowance for credit losses of $ 17 and $ 11 at March 31, 2026 and December 31, 2025, respectively (amortized cost: 2026 $ 52,356 ; 2025 $ 50,491 ) $ 48,597 $ 47,321 Debt Securities, at fair value under fair value option 3,351 3,470 Equity securities, at fair value 243 172 Mortgage loans, net of allowance for credit losses of $ 159 and $ 133 at March 31, 2026 and December 31, 2025, respectively 10,248 9,887 Mortgage loans, at fair value under fair value option 196 324 Policy loans (including $ 3,556 and $ 3,537 at fair value under the fair value option at March 31, 2026 and December 31, 2025, respectively) 4,431 4,426 Freestanding derivative instruments 701 448 Other invested assets 3,246 3,185 Total investments 71,013 69,233 Cash and cash equivalents 5,539 5,704 Accrued investment income 636 634 Deferred acquisition costs 11,634 11,660 Reinsurance recoverable, net of allowance for credit losses of $ 30 and $ 30 at March 31, 2026 and December 31, 2025, respectively 18,926 19,518 Reinsurance recoverable on market risk benefits, at fair value 121 118 Market risk benefit assets, at fair value 6,701 7,867 Deferred income taxes, net 610 719 Other assets 905 637 Separate account assets 223,452 236,496 Total assets $ 339,537 $ 352,586 Liabilities and Equity Liabilities Reserves for future policy benefits and claims payable $ 10,706 $ 10,896 Other contract holder funds 68,703 67,663 Market risk benefit liabilities, at fair value 3,971 3,754 Funds withheld payable under reinsurance treaties (including $ 3,744 and $ 3,723 at fair value under the fair value option at March 31, 2026 and December 31, 2025, respectively) 14,511 14,960 Long-term debt 2,027 2,030 Repurchase agreements and securities lending payable 505 1,036 Collateral payable for derivative instruments 343 58 Freestanding derivative instruments 238 257 Notes issued by consolidated variable interest entities, at fair value under fair value option (see Note 4) 2,543 2,578 Other liabilities 2,638 2,516 Separate account liabilities 223,452 236,496 Total liabilities 329,637 342,244 Commitments, Contingencies, and Guarantees (see Note 16) Equity Series A non-cumulative preferred stock and additional paid in capital, $ 1.00 par value per share: 24,000 shares authorized; 22,000 shares issued and outstanding at March 31, 2026 and December 31, 2025; liquidation preference $ 25,000 per share (see Note 19) 533 533 Common stock; 1,000,000,000 shares authorized, $ 0.01 par value per share and 70,270,752 and 66,825,632 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively (see Note 19) 1 1 Additional paid-in capital 6,393 6,063 Treasury stock, at cost; 24,217,563 and 27,662,683 shares at March 31, 2026 and December 31, 2025, respectively ( 1,671 ) ( 1,645 ) Accumulated other comprehensive income (loss), net of tax expense (benefit) of $( 287 ) and $( 377 ) at March 31, 2026 and December 31, 2025, respectively ( 2,728 ) ( 2,470 ) Retained earnings 6,968 7,471 Total shareholders' equity 9,496 9,953 Noncontrolling interests 404 389 Total equity 9,900 10,342 Total liabilities and equity $ 339,537 $ 352,586 See Notes to Condensed Consolidated Financial Statements. 2 Jackson Financial Inc. Condensed Consolidated Income Statements (Unaudited, in millions, except per share data) Three Months Ended March 31, 2026 2025 Revenues Fee income $ 1,998 $ 1,986 Premiums 28 40 Net investment income: Net investment income excluding funds withheld assets 541 528 Net investment income on funds withheld assets 199 227 Total net investment income 740 755 Net gains (losses) on derivatives and investments: Net gains (losses) on derivatives and investments 283 1,343 Net gains (losses) on funds withheld reinsurance treaties ( 159 ) ( 388 ) Total net gains (losses) on derivatives and investments 124 955 Other income 12 14 Total revenues 2,902 3,750 Benefits and Expenses Death, other policy benefits and change in policy reserves, net of deferrals 258 244 (Gain) loss from updating future policy benefits cash flow assumptions, net 18 12 Market risk benefits (gains) losses, net 1,670 2,246 Interest credited on other contract holder funds, net of deferrals and amortization 315 288 Interest expense 25 25 Operating costs and other expenses, net of deferrals 735 677 Amortization of deferred acquisition costs 281 275 Total benefits and expenses 3,302 3,767 Pretax income (loss) ( 400 ) ( 17 ) Income tax expense (benefit) 20 1 Net income (loss) ( 420 ) ( 18 ) Less: Net income (loss) attributable to noncontrolling interests 4 6 Net income (loss) attributable to Jackson Financial Inc. ( 424 ) ( 24 ) Less: Dividends on preferred stock 11 11 Net income (loss) attributable to Jackson Financial Inc. common shareholders $ ( 435 ) $ ( 35 ) Earnings per share Basic $ ( 6.24 ) $ ( 0.48 ) Diluted $ ( 6.24 ) $ ( 0.48 ) See Notes to Condensed Consolidated Financial Statements. 3 Jackson Financial Inc. Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited, in millions) Three Months Ended March 31, 2026 2025 Net income (loss) $ ( 420 ) $ ( 18 ) Other comprehensive income (loss), net of tax: Change in unrealized gains (losses) on securities with no credit impairment, net of tax expense (benefit) of: $ 2 and $ 40 , for the three months ended March 31, 2026 and 2025, respectively ( 552 ) 607 Change in unrealized gains (losses) on securities with credit impairment, net of tax expense (benefit) of: nil and nil , for the three months ended March 31, 2026 and 2025, respectively ( 24 ) ( 1 ) Change in current discount rate related to reserve for future policy benefits, net of tax expense (benefit) of $ 16 and $( 16 ), for the three months ended March 31, 2026 and 2025, respectively 57 ( 59 ) Change in non-performance risk on market risk benefits, net of tax expense (benefit) of $ 72 and $ 71 , for the three months ended March 31, 2026 and 2025, respectively 261 256 Total other comprehensive income (loss) ( 258 ) 803 Comprehensive income (loss) ( 678 ) 785 Less: Comprehensive income (loss) attributable to noncontrolling interests 4 6 Comprehensive income (loss) attributable to Jackson Financial Inc. $ ( 682 ) $ 779 See Notes to Condensed Consolidated Financial Statements. 4 Jackson Financial Inc. Condensed Consolidated Statements of Equity (Unaudited, in millions) Accumulated Additional Treasury Other Total Non- Preferred Common Paid-In Stock Comprehensive Retained Shareholders' Controlling Total Stock Stock Capital at Cost Income Earnings Equity Interests Equity Balances as of December 31, 2025 $ 533 $ 1 $ 6,063 $ ( 1,645 ) $ ( 2,470 ) $ 7,471 $ 9,953 $ 389 $ 10,342 Net income (loss) — — — — — ( 424 ) ( 424 ) 4 ( 420 ) Other comprehensive income (loss) — — — — ( 258 ) — ( 258 ) — ( 258 ) Change in equity of noncontrolling interests — — — — — — — 11 11 Dividends on preferred stock — — — — — ( 11 ) ( 11 ) — ( 11 ) Dividends on common stock — — — — — ( 65 ) ( 65 ) — ( 65 ) Purchase of treasury stock — — — ( 227 ) — — ( 227 ) — ( 227 ) Issuance of treasury stock — — 322 178 — — 500 — 500 Share based compensation — — 8 23 — ( 3 ) 28 — 28 Balances as of March 31, 2026 $ 533 $ 1 $ 6,393 $ ( 1,671 ) $ ( 2,728 ) $ 6,968 $ 9,496 $ 404 $ 9,900 Accumulated Additional Treasury Other Total Non- Preferred Common Paid-In Stock Comprehensive Retained Shareholders' Controlling Total Stock Stock Capital at Cost Income Earnings Equity Interests Equity Balances as of December 31, 2024 $ 533 $ 1 $ 6,046 $ ( 1,007 ) $ ( 3,522 ) $ 7,713 $ 9,764 $ 218 $ 9,982 Net income (loss) — — — — — ( 24 ) ( 24 ) 6 ( 18 ) Other comprehensive income (loss) — — — — 803 — 803 — 803 Change in equity of noncontrolling interests — — — — — — — — — Dividends on preferred stock — — — — — ( 11 ) ( 11 ) — ( 11 ) Dividends on common stock — — — — — ( 59 ) ( 59 ) — ( 59 ) Purchase of treasury stock — — — ( 202 ) — — ( 202 ) — ( 202 ) Share based compensation — — ( 4 ) 30 — 4 30 — 30 Balances as of March 31, 2025 $ 533 $ 1 $ 6,042 $ ( 1,179 ) $ ( 2,719 ) $ 7,623 $ 10,301 $ 224 $ 10,525 See Notes to Condensed Consolidated Financial Statements. 5 Jackson Financial Inc. Condensed Consolidated Statements of Cash Flows (Unaudited, in millions) Three Months Ended March 31, 2026 2025 Cash flows from operating activities: Net income (loss) $ ( 420 ) $ ( 18 ) Adjustments to reconcile net income to net cash provided by operating activities: Net realized losses (gains) on investments 47 66 Net losses (gains) on derivatives ( 330 ) ( 1,409 ) Net losses (gains) on funds withheld reinsurance treaties 159 388 Net (gain) loss on market risk benefits 1,670 2,246 (Gain) loss from updating future policy benefits cash flow assumptions, net 18 12 Interest credited on other contract holder funds, gross 315 288 Mortality, expense and surrender charges ( 127 ) ( 133 ) Amortization of discount and premium on investments ( 14 ) ( 8 ) Deferred income tax expense (benefit) 19 2 Share-based compensation 60 54 Change in: Accrued investment income ( 2 ) ( 6 ) Deferred acquisition costs 26 117 Funds withheld, net of reinsurance 120 134 Future policy benefits ( 129 ) ( 137 ) Other assets and liabilities, net ( 367 ) ( 2 ) Net cash provided by (used in) operating activities 1,045 1,594 Cash flows from investing activities: Sales, maturities and repayments of: Debt securities 2,353 2,027 Equity securities 16 4 Mortgage loans 463 272 Purchases of: Debt securities ( 4,009 ) ( 3,333 ) Equity securities — — Mortgage loans ( 724 ) ( 392 ) Settlements related to derivatives and collateral on investments ( 471 ) 742 Other investing activities ( 58 ) ( 273 ) Net cash provided by (used in) investing activities ( 2,430 ) ( 953 ) (continued) See Notes to Condensed Consolidated Financial Statements. 6 Jackson Financial Inc. Condensed Consolidated Statements of Cash Flows (continued) (Unaudited, in millions) Three Months Ended March 31, 2026 2025 Cash flows from financing activities: Policyholders' account balances: Deposits $ 7,334 $ 5,804 Withdrawals ( 11,187 ) ( 10,226 ) Net transfers from (to) separate accounts 5,402 5,205 Proceeds from (payments on) repurchase agreements and securities lending ( 531 ) ( 517 ) Net proceeds from (payments on) Federal Home Loan Bank notes — ( 700 ) Settlements related to deferred premium on derivatives ( 154 ) — Payments on debt ( 4 ) ( 4 ) Pre-capitalized trust securities issuance costs ( 7 ) — Issuance of debt of consolidated investment entities 96 215 Repayments of debt of consolidated investment entities ( 35 ) ( 27 ) Contributions from partners of consolidated investments 108 — Dividends on common stock ( 64 ) ( 58 ) Dividends on preferred stock ( 11 ) ( 11 ) Purchase of treasury stock ( 227 ) ( 202 ) Issuance of treasury stock 500 — Net cash provided by (used in) financing activities 1,220 ( 521 ) Net increase (decrease) in cash, cash equivalents, and restricted cash ( 165 ) 120 Cash, cash equivalents, and restricted cash at beginning of period 5,704 3,767 Total cash, cash equivalents, and restricted cash at end of period $ 5,539 $ 3,887 Supplemental cash flow information Income taxes paid (received) $ ( 48 ) $ ( 20 ) Interest paid $ 24 $ 42 Non-cash investing activities Debt securities acquired from exchanges, payments-in-kind, and similar transactions $ 37 $ 53 TPG Inc common stock acquired $ 150 $ — Non-cash financing activities Non-cash dividend equivalents on stock-based awards $ ( 1 ) $ ( 1 ) Reconciliation to Condensed Consolidated Balance Sheets Cash and cash equivalents $ 5,539 $ 3,887 Restricted cash (included in Other assets) — — Total cash, cash equivalents, and restricted cash $ 5,539 $ 3,887 See Notes to Condensed Consolidated Financial Statements. 7 Jackson Financial Inc. Notes to Condensed Consolidated Financial Statements (Unaudited) 1. Business and Basis of Presentation Jackson Financial Inc. ("JFI" or “Jackson Financial”) together with its subsidiaries (the “Company,” which also may be referred to as “we,” “our” or “us”), is a financial services company focused on helping Americans secure their financial futures. Jackson Financial is domiciled in the state of Delaware in the United States (“U.S.”). Jackson Financial’s primary life insurance subsidiary, Jackson National Life Insurance Company and its insurance subsidiaries (collectively, “Jackson”), is licensed to sell group and individual annuity products (including variable, registered index-linked, fixed index, fixed and payout annuities), and individual life insurance products, including variable universal life, in all 50 states and the District of Columbia. Jackson also participates in the institutional products market through the issuance of guaranteed investment contracts (“GICs”) and funding agreements. In addition to Jackson, Jackson Financial’s operating subsidiaries include: • PPM America, Inc. (“PPM”), a registered investment adviser, is the Company’s investment management operation that manages the life insurance companies’ general account investment funds. PPM also provides investment services to other institutional clients globally; • Brooke Life Insurance Company (“Brooke Life”), the direct parent of Jackson, is a Michigan life insurance company licensed to sell life insurance and annuity products in the state of Michigan; • Brooke Life Reinsurance Company ("Brooke Re"), also a direct subsidiary of Brooke Life, was formed as a Michigan captive reinsurance company; and • Hickory Brooke Reinsurance Company ("Hickory Re"), a direct subsidiary of Brooke Re, was formed as a Michigan captive reinsurance company. Significant wholly-owned subsidiaries of Jackson are as follows: • Life insurers: Jackson National Life Insurance Company of New York; Squire Reassurance Company II, Inc.; and VFL International Life Company SPC, LTD; • Registered broker-dealer: Jackson National Life Distributors LLC; and • Registered investment adviser: Jackson National Asset Management LLC (“JNAM”) manages the life insurance companies' separate account funds underlying our variable annuities products, of which the majority of the funds are sub-advised. JNAM manages and oversees those sub-advisers. The Company's Condensed Consolidated Financial Statements also include other insignificant partnerships, limited liability companies (“LLCs”), and other variable interest entities (“VIEs”) in which the Company is deemed the primary beneficiary. Brooke Life Reinsurance Company During the first quarter of 2024, Jackson entered into a reinsurance transaction with Brooke Re and all economics of the transaction were effective as of January 1, 2024. The reinsurance transaction primarily provides for the cession from Jackson to Brooke Re of liabilities associated with certain guaranteed benefit riders under variable annuity contracts and similar products of Jackson (constituting “market risk benefits”), both in-force on the effective date of the reinsurance agreement and written in the future ( i.e. , on a “flow” basis). Since Jackson and Brooke Re are subsidiaries of JFI, the reinsurance transaction eliminates upon consolidation at JFI. For regulatory reporting purposes, Brooke Re utilizes a modified U.S. generally accepted accounting principles ("U.S. GAAP") approach, primarily related to market risk benefits, with the intent to increase alignment between assets and liabilities in response to changes in economic factors. The reinsurance transaction and related modified U.S. GAAP approach allows us to mitigate the impact of the cash surrender value floor on Jackson’s total adjusted capital, statutory required capital, and risk-based capital ratio, as well as allows for more efficient economic hedging of the underlying risks of Jackson’s business. 8 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 1. Business and Basis of Presentation Hickory Brooke Reinsurance Company During the fourth quarter of 2025, Jackson entered into a reinsurance agreement with Hickory Re, on a quota-share coinsurance basis on certain fixed annuities and fixed index annuities issued by Jackson, including the annuitization of these contracts, with all economics of the transaction effective as of December 1, 2025. Additionally, under the agreement Hickory Re will reinsure the new sales of fixed annuities and fixed index annuities of Jackson. Since Jackson and Hickory Re are subsidiaries of JFI, the reinsurance transaction eliminates upon consolidation at JFI. For regulatory reporting purposes, Hickory Re measures the liabilities for assumed contracts using a modified U.S. GAAP methodology which is intended to increase alignment between assets and liabilities in response to changes in economic factors. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. GAAP for interim financial information. Accordingly, certain financial information that is normally included in annual financial statements prepared in accordance with U.S. GAAP, but not required for interim reporting purposes, has been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on February 24, 2026 (the "2025 Annual Report"). The condensed consolidated financial information as of December 31, 2025, included herein, has been derived from the audited Consolidated Financial Statements in the 2025 Annual Report. Certain accounting policies, which significantly affect the determination of the Company's financial condition, results of operations and cash flows, are summarized in the Notes to Consolidated Financial Statements in the 2025 Annual Report. In the opinion of management, these Condensed Consolidated Financial Statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Operating results for the three months ended March 31, 2026, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2026. All material intercompany accounts and transactions have been eliminated upon consolidation. All prior period amounts have been conformed to the current period presentation. Use of Estimates The preparation of these Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in these notes, include: • Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary; • Assumptions used in calculating policy reserves and liabilities, including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates; • Estimates related to expectations of credit losses on certain financial assets and off-balance sheet exposures; • Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company, and assumptions as to future earnings levels being sufficient to realize deferred tax benefits; • Assumptions used in calculating market risk benefits, including policyholder behavior, mortality rates, and capital market assumptions; and • Assumptions impacting the expected term used in amortizing deferred acquisition costs, including policyholder behavior and mortality rates. These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other appropriate factors. As facts and circumstances evolve, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. The effects of changes in estimates and assumptions, including those resulting from changing expectations with respect to the economic environment, will be reflected in the consolidated financial statements covering the periods in which the estimates are changed. 9 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 2. New Accounting Standards 2. New Accounting Standards Accounting Pronouncements – Issued but Not Yet Adopted In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2024-03, “Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40),” which requires disaggregated disclosure of income statement expenses for public business entities. The ASU requires footnote disclosure about specific types of expenses included in certain expense captions presented on the face of the income statement and the total amount of selling expenses on an annual and interim basis. The entity is also required to disclose its definition of selling expenses in annual reporting periods. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is in the process of evaluating the impact of the new guidance and determining the transition method and the timing of adoption. In September 2025, the FASB issued ASU 2025-06, “Intangibles – Goodwill and Other – Internal-use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-use Software.” Under the new standard, an entity will start capitalizing eligible software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended (referred to as the “probable-to-complete recognition threshold”). The amendments in this ASU will be effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The amendments can be applied on a fully prospective basis, a modified basis for in-process projects, or a fully retrospective basis. The Company is in the process of evaluating the impact of the new guidance and determining the transition method and the timing of adoption. In December 2025, the FASB issued ASU 2025-08, “Financial Instruments – Credit Losses (Topic 326): Purchased Loans,” which requires certain purchased seasoned loans acquired without credit deterioration be accounted for using the gross-up approach in Topic 326 that is currently applied to purchased with credit deterioration (“PCD”) financial assets. Under the gross-up approach, the initial allowance for credit losses is established by increasing the amortized cost basis of the loan rather than recognizing a charge to credit loss expense. The amendments in this ASU will be effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted in an interim or annual reporting period in which financial statements have not yet been issued or made available for issuance. The amendments are to be applied prospectively. The Company is in the process of evaluating the impact of the new guidance and the timing of adoption. In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow Scope Improvements”, which provides additional guidance on what disclosures should be provided in interim reporting periods including disclosure of events since the end of the last annual reporting period that have a material impact on the entity. The amendments in this ASU will be effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments in this ASU can be applied either prospectively or retrospectively to any or all prior periods presented in the financial statements. The Company is in the process of evaluating the impact of the new guidance and determining the transition method and the timing of adoption. 3. Segment Information The Company has three reportable segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks. The Company reports, in Corporate and Other, certain activities and items that are not included in these reportable segments, including the results of PPM Holdings, Inc., the holding company of PPM, which manages the majority of the Company’s general account investment portfolio. The reportable segments reflect how the Company’s chief operating decision maker (the "CODM") views and manages the business. The Company’s CODM function is performed jointly by our Chief Executive Officer and our Chief Financial Officer. For our three reportable segments, the CODM uses segment pretax adjusted operating earnings to allocate resources for each segment (predominantly through our annual budget and forecasting process) and to assess the performance of each segment (primarily by comparing the results of each segment with one another) with planned and forecasted results, and compared to prior period results. The following is a brief description of each of the Company’s reportable segments, plus its Corporate and Other segment. 10 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information Retail Annuities The Company’s Retail Annuities segment offers a variety of retirement income and savings products through its diverse suite of products, consisting primarily of variable annuities, registered index-linked annuities ("RILA"), fixed annuities, fixed index annuities, and payout annuities. These products are distributed through various wirehouses, insurance brokers and independent broker-dealers, as well as through banks and financial institutions. The Company’s variable annuities represent an attractive option for retirees and soon-to-be retirees, providing access to equity market appreciation and add-on benefits, including guaranteed lifetime income. A RILA offers customers access to market returns through market index-linked investment options, subject to a cap, and offers a variety of features designed to modify or limit losses. A fixed index annuity is designed for investors who desire principal protection with the opportunity to participate in capped upside investment returns linked to a reference market index. A fixed annuity is a guaranteed product designed to build wealth without market exposure, through a crediting rate that is likely to be superior to interest rates offered by banks or money market funds. The financial results of the variable annuity business within the Company’s Retail Annuities segment are largely dependent on the performance of the contract holder account value, which impacts both the level of fees collected and the benefits paid to the contract holder. The financial results of the Company’s fixed annuities, fixed index annuities, RILA and the fixed option on variable annuities, are largely dependent on the Company’s ability to earn a spread between earned investment rates on general account assets and the interest credited to contract holders. Institutional Products The Company’s Institutional Products segment consists of traditional guaranteed investment contracts ("GICs") and funding agreements. The Company’s GIC products are marketed to defined contribution pension and profit-sharing retirement plans. Funding agreements are marketed to institutional investors, including corporate cash accounts and securities lending funds, as well as money market funds. Funding agreements are also issued in conjunction with the Company's participation in the U.S. Federal Home Loan Bank ("FHLB") program. The financial results of the Company’s institutional products business are primarily dependent on the Company’s ability to earn a spread between earned investment rates on general account assets and the interest credited on GICs and funding agreements. Closed Life and Annuity Blocks The Company's Closed Life and Annuity Blocks segment is primarily composed of blocks of business that have been acquired since 2004. This segment includes various protection products, primarily whole life, universal life, variable universal life, and term life insurance products, as well as fixed, fixed index, and payout annuities. The Company historically offered traditional and interest-sensitive life insurance products but discontinued new sales of life insurance products in 2012, as we believe opportunistically acquiring mature blocks of life insurance policies is a more efficient means of diversifying our in-force business than selling new life insurance products. The profitability of the Company’s Closed Life and Annuity Blocks segment is largely driven by its historical ability to appropriately price its products and purchase appropriately priced blocks of business, as realized through underwriting, expense and net gains (losses) on derivatives and investments, and the ability to earn an assumed rate of return on the assets supporting that business. Corporate and Other The Company’s Corporate and Other segment primarily consists of the operations of its investment management subsidiary, PPM, VIEs, and unallocated corporate income and expenses. The Corporate and Other segment also includes intersegment eliminations and consolidation adjustments. 11 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information Segment Performance Measurement Segment operating revenues and pretax adjusted operating earnings are non-GAAP financial measures that management believes are critical to the evaluation of the financial performance of the Company’s segments. The Company uses the same accounting policies and procedures to measure segment pretax adjusted operating earnings as used in its reporting of consolidated net income. Its primary measure is pretax adjusted operating earnings, which is defined as net income reported in accordance with U.S. GAAP, excluding certain items that may be highly variable from period to period due to accounting treatment under U.S. GAAP, or that are non-recurring in nature, as well as certain other revenues and expenses that are not considered drivers of underlying performance. Operating revenues and pretax adjusted operating earnings should not be used as a substitute for revenues and net income, respectively, as calculated in accordance with U.S. GAAP. Pretax adjusted operating earnings equals net income adjusted to eliminate the impact of the items described in the following numbered paragraphs. These items are excluded from pretax adjusted operating earnings as they may vary significantly from period to period due to near-term market conditions and, therefore, are not directly comparable or reflective of the underlying performance of our business. We believe these exclusions provide investors a better picture of the drivers of our underlying performance. 1. Net Hedging Results: Comprised of: (i) fees attributed to guaranteed benefits; (ii) net gains (losses) on hedging instruments that includes: (a) changes in the fair value of freestanding derivatives, and related commissions and expenses, used to manage the risk associated with market risk benefits and other benefit features, excluding earned income from periodic settlements and changes in settlement accruals on cross-currency swaps; and (b) investment income and change in fair value of certain non-derivative assets used to manage the risk associated with market risk benefits and other benefit features; and (iii) the movements in reserves, market risk benefits, benefit features accounted for as embedded derivative instruments adjusted to exclude the cost of hedging for certain indexed annuity products, and related claims and benefit payments (excluding impacts of actuarial assumption updates and model enhancements). We believe excluding these items removes the impact to both revenue and related expenses associated with Net Hedging Results. 2. Amortization of DAC Associated with Non-operating Items at Date of Transition to LDTI: Amortization of the balance of unamortized deferred acquisition costs ("DAC"), at January 1, 2021, the date of transition to current Long Duration Targeted Improvements ("LDTI") accounting guidance, associated with items excluded from pretax adjusted operating earnings prior to transition. 3. Actuarial Assumption Updates and Model Enhancements: The impact on the valuation of market risk benefits and embedded derivatives arising from our annual actuarial assumption updates and model enhancements review. 4. Net Realized Investment Gains and Losses: Comprised of: (i) realized investment gains and losses associated with the periodic sales or disposals of securities, excluding those held within our trading portfolio; (ii) impairments of securities, after adjustment for the non-credit component of the impairment charges; and (iii) foreign currency gain or loss on foreign denominated funding agreements and associated cross-currency swaps. 5. Change in Value of Funds Withheld Embedded Derivative and Net Investment Income on Funds Withheld Assets: Comprised of: (i) the change in fair value of funds withheld embedded derivatives, and (ii) net investment income on funds withheld assets related to funds withheld reinsurance transactions. 6. Other Items: Comprised of: (i) the impact of investments that are consolidated in our financial statements due to U.S. GAAP accounting requirements, such as our investments in collateralized loan obligations ("CLOs"), but for which the consolidation effects are not consistent with our economic interest or exposure to those entities; (ii) impacts from derivatives not included in Net Hedging Results or Net Realized Investment Gains or Losses (see 1. and 4. above), excluding earned income from periodic settlements and changes in settlement accruals on cross-currency swaps; (iii) investment income (loss) related to mark-to-market on TPG shares, which are subject to certain sales restrictions; and (iv) one-time or other non-recurring items. 7. Income Taxes. 12 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information Set forth in the tables below is certain information with respect to the Company’s segments (in millions): Three Months Ended March 31, 2026 Retail Annuities Institutional Products Closed Life and Annuity Blocks Corporate and Other Total Consolidated Operating Revenues Fee income $ 1,111 $ — $ 103 $ 11 $ 1,225 Premiums 5 — 25 — 30 Net investment income 320 143 146 8 617 Other income (loss) 6 — 6 — 12 Total Operating Revenues 1,442 143 280 19 1,884 Operating Benefits and Expenses Death, other policy benefits and change in policy reserves, net of deferrals 30 — 171 — 201 (Gain) loss from updating future policy benefits cash flow assumptions, net ( 1 ) — 16 — 15 Interest credited 118 114 86 — 318 Interest expense 6 — — 19 25 Asset-based commission expenses 295 — — — 295 Other commission expenses 315 — 7 — 322 Sub-advisor expenses 76 — — ( 2 ) 74 General and administrative expenses 232 1 27 39 299 Deferral of acquisition costs ( 255 ) — — — ( 255 ) Amortization of deferred acquisition costs 158 — 2 — 160 Total Operating Benefits and Expenses 974 115 309 56 1,454 Pretax Adjusted Operating Earnings $ 468 $ 28 $ ( 29 ) $ ( 37 ) $ 430 Three Months Ended March 31, 2025 Retail Annuities Institutional Products Closed Life and Annuity Blocks Corporate and Other Total Consolidated Operating Revenues Fee income $ 1,095 $ — $ 108 $ 12 $ 1,215 Premiums 14 — 29 — 43 Net investment income 187 116 187 11 501 Other income 7 — 6 1 14 Total Operating Revenues 1,303 116 330 24 1,773 Operating Benefits and Expenses Death, other policy benefits and change in policy reserves, net of deferrals 29 — 154 — 183 (Gain) loss from updating future policy benefits cash flow assumptions, net ( 3 ) — 14 — 11 Interest credited 94 97 97 — 288 Interest expense 6 — — 19 25 Asset-based commission expenses 284 — — — 284 Other commission expenses 206 — 9 — 215 Sub-advisor expenses 80 — — ( 2 ) 78 General and administrative expenses 200 1 27 31 259 Deferral of acquisition costs ( 158 ) — ( 1 ) — ( 159 ) Amortization of deferred acquisition costs 145 — 2 — 147 Total Operating Benefits and Expenses 883 98 302 48 1,331 Pretax Adjusted Operating Earnings $ 420 $ 18 $ 28 $ ( 24 ) $ 442 13 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information Intersegment eliminations in the above tables are included in the Corporate and Other segment. These include the elimination of investment income between Retail Annuities and the Corporate and Other segments, as well as the elimination from fee income and investment income of investment fees paid by Jackson Financial and its subsidiaries to PPM, which were $ 27 million and $ 21 million for the three months ended March 31, 2026 and 2025, respectively . The following table summarizes the reconciling items from the non-GAAP measure of total operating revenues to the U.S. GAAP measure of total revenues attributable to the Company (in millions): Three Months Ended March 31, 2026 2025 Total operating revenues $ 1,884 $ 1,773 Fees attributed to guarantee benefit reserves 771 768 Net gains (losses) on hedging instruments and investments 120 982 Investment income (loss) related to mark-to-market on TPG shares ( 58 ) — Net investment income (loss) related to noncontrolling interests 4 6 Consolidated investments ( 18 ) ( 6 ) Net investment income on funds withheld assets 199 227 Total revenues (1) $ 2,902 $ 3,750 (1) Substantially all the Company's revenues originated in the U.S. There were no customers that, individually, generated revenues that exceeded 10% of total revenues attributable to the Company. The following table summarizes the reconciling items from the non-GAAP measure of total operating benefits and expenses to the U.S. GAAP measure of total benefits and expenses attributable to the Company (in millions): Three Months Ended March 31, 2026 2025 Total operating benefits and expenses $ 1,454 $ 1,331 Net (gain) loss on market risk benefits 1,670 2,246 Benefits attributed to guaranteed benefit features 60 62 Amortization of DAC related to non-operating revenues and expenses 121 128 Cost of hedging ( 3 ) — Total benefits and expenses $ 3,302 $ 3,767 14 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information The following table summarizes the reconciling items, from the non-GAAP measure of pretax adjusted operating earnings to the U.S. GAAP measure of net income attributable to the Company (in millions): Three Months Ended March 31, 2026 2025 Pretax adjusted operating earnings $ 430 $ 442 Pre-tax reconciling items from adjusted operating income to net income (loss) attributable to Jackson Financial Inc.: Fees attributable to guarantee benefit reserves 771 768 Net gains (losses) on hedging instruments ( 460 ) 1,011 Market risk benefits gains (losses), net ( 1,670 ) ( 2,246 ) Net reserve and embedded derivative movements 707 333 Total net hedging results ( 652 ) ( 134 ) Amortization of DAC associated with non-operating items at date of transition to LDTI ( 121 ) ( 128 ) Net realized investment gains (losses) ( 42 ) ( 66 ) Net realized investment gains (losses) on funds withheld assets ( 159 ) ( 388 ) Net investment income on funds withheld assets 199 227 Other items ( 59 ) 24 Pretax income (loss) attributable to Jackson Financial Inc. ( 404 ) ( 23 ) Income tax expense (benefit) 20 1 Net income (loss) attributable to Jackson Financial Inc. ( 424 ) ( 24 ) Less: Dividends on preferred stock 11 11 Net income (loss) attributable to Jackson Financial Inc. common shareholders $ ( 435 ) $ ( 35 ) The following table summarizes total assets by segment (in millions): March 31, 2026 December 31, 2025 Retail Annuities $ 295,091 $ 307,225 Closed Life and Annuity Blocks 26,493 26,988 Institutional Products 12,605 12,869 Corporate and Other 5,348 5,504 Total Assets $ 339,537 $ 352,586 15 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments 4. Investments Investments consist primarily of fixed-income securities and loans, principally publicly-traded corporate and government bonds, asset-backed securities and mortgage loans. Asset-backed securities include mortgage-backed and other structured securities. The Company generates the majority of its general account deposits from interest-sensitive individual annuity contracts, life insurance products and institutional products on which it has committed to pay a declared rate of interest. The Company's strategy of investing in fixed-income securities and loans seeks to match the asset yield with the amounts credited to the interest-sensitive liabilities and to earn a stable return on its investments. Long-term Strategic Partnership with TPG During the first quarter of 2026, Jackson entered a long-term strategic partnership with TPG, combining Jackson’s annuity product expertise and broad distribution network with TPG’s private credit platform. The partnership aims to expand Jackson’s spread-based product sales. The transaction closed on February 11, 2026. At the closing, subsidiaries and affiliates of Jackson Financial and TPG entered into non-exclusive investment management arrangements with a 10 -year initial term with automatic 1 -year renewals through year 15 (subject to various termination rights), with TPG providing Investment Grade Asset Based Finance and Direct Lending investment capabilities to complement the asset management capabilities of PPM America, Inc. ("PPM"), a Jackson Financial subsidiary. The arrangement contemplates certain target AUM levels over time and related investment management fees (including a baseline minimum fee payment), subject to exceptions, that the Company is committed to pay during the term of the agreements and any applicable wind-down period. PPM will continue to manage the majority of Jackson’s general account and both Jackson and PPM will retain oversight of Jackson’s investment portfolio. TPG acquired a $ 500 million equity stake in Jackson Financial. See Note 19 - Equity of these Notes to Condensed Consolidated Financial Statements for more information regarding the shares issued to TPG. Additionally, TPG issued to a wholly owned, indirect subsidiary of Jackson $ 150 million in TPG common shares, which was reported in equity securities, at fair value on the Condensed Consolidated Balance Sheets. Under the terms of the transaction, TPG and Jackson have agreed to certain limitations on their ability to divest their respective ownership stakes over time. Debt Securities The following table sets forth the composition of the fair value of debt securities at March 31, 2026, and December 31, 2025, classified by rating categories as assigned by a nationally recognized statistical rating organization (a “rating agency”), National Association of Insurance Commissioners (the “NAIC”) or, if not rated by such organizations, the Company’s investment advisors. The Company uses the second lowest rating by a rating agency when rating agencies' ratings are not equivalent and, for purposes of the table, if not otherwise rated by a rating agency, the NAIC rating of a security is converted to an equivalent rating agency rating. At March 31, 2026 and December 31, 2025, the carrying value of investments rated by the Company’s consolidated investment advisor totaled $ 839 million and $ 606 million, respectively. Percent of Total Debt Securities Carrying Value March 31, 2026 December 31, 2025 Investment Rating U.S. government securities 6.0 % 5.9 % AAA 4.8 % 5.0 % AA 9.4 % 9.5 % A 32.5 % 32.2 % BBB 41.2 % 40.9 % Investment grade 93.9 % 93.5 % BB 2.3 % 2.5 % B and below 3.8 % 4.0 % Below investment grade 6.1 % 6.5 % Total debt securities 100.0 % 100.0 % 16 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments At March 31, 2026 and December 31, 2025, the total carrying value of debt securities in an unrealized loss position consisted of: March 31, 2026 December 31, 2025 Investment grade securities 79 % 78 % Below investment grade securities 1 % 1 % Not rated securities 20 % 21 % Unrealized losses on debt securities that were below investment grade or not rated were approximately 18 % and 19 % of the aggregate gross unrealized losses on available-for-sale debt securities at March 31, 2026 and December 31, 2025, respectively. Corporate securities in an unrealized loss position were diversified across industries. As of March 31, 2026, the industries accounting for the largest percentage of unrealized losses included utility ( 19 % of corporate gross unrealized losses) and healthcare ( 12 %). The largest unrealized loss related to a single corporate obligor was $ 58 million at March 31, 2026. As of December 31, 2025, the industries accounting for the largest percentage of unrealized losses included utility ( 18 % of corporate gross unrealized losses) and financial services ( 13 %). The largest unrealized loss related to a single corporate obligor was $ 55 million at December 31, 2025. At March 31, 2026 and December 31, 2025, the amortized cost, allowance for credit loss ("ACL"), gross unrealized gains and losses, and fair value of debt securities, including trading securities and securities carried at fair value under the fair value option, were as follows (in millions): Allowance Gross Gross Amortized for Unrealized Unrealized Fair March 31, 2026 Cost (1) Credit Loss Gains Losses Value U.S. government securities $ 3,989 $ — $ 1 $ 865 $ 3,125 Other government securities 1,255 — 2 202 1,055 Public utilities 6,696 — 46 530 6,212 Corporate securities 35,124 6 245 2,255 33,108 Residential mortgage-backed 473 1 21 26 467 Commercial mortgage-backed 2,010 — 5 61 1,954 Other asset-backed securities 6,160 10 17 140 6,027 Total debt securities $ 55,707 $ 17 $ 337 $ 4,079 $ 51,948 Allowance Gross Gross Amortized for Unrealized Unrealized Fair December 31, 2025 Cost (1) Credit Loss Gains Losses Value U.S. government securities $ 3,854 $ — $ 2 $ 851 $ 3,005 Other government securities 1,254 — 4 193 1,065 Public utilities 6,529 — 75 458 6,146 Corporate securities 34,515 — 443 2,042 32,916 Residential mortgage-backed 445 4 24 23 442 Commercial mortgage-backed 1,873 — 10 54 1,829 Other asset-backed securities 5,491 7 34 130 5,388 Total debt securities $ 53,961 $ 11 $ 592 $ 3,751 $ 50,791 (1) Amortized cost, apart from the carrying value for securities carried at fair value under the fair value option and trading securities. 17 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments The amortized cost, ACL, gross unrealized gains and losses, and fair value of debt securities at March 31, 2026, by contractual maturity, are shown below (in millions). Actual maturities may differ from contractual maturities where securities can be called or prepaid with or without early redemption penalties. Allowance Gross Gross Amortized for Unrealized Unrealized Fair Cost (1) Credit Loss Gains Losses Value Due in 1 year or less $ 1,794 $ — $ 2 $ 6 $ 1,790 Due after 1 year through 5 years 14,271 — 92 394 13,969 Due after 5 years through 10 years 13,927 — 144 384 13,687 Due after 10 years through 20 years 9,633 6 48 1,430 8,245 Due after 20 years 7,439 — 8 1,638 5,809 Residential mortgage-backed 473 1 21 26 467 Commercial mortgage-backed 2,010 — 5 61 1,954 Other asset-backed securities 6,160 10 17 140 6,027 Total $ 55,707 $ 17 $ 337 $ 4,079 $ 51,948 (1) Amortized cost, apart from the carrying value for securities carried at fair value under the fair value option and trading securities. As required by law in various states in which business is conducted, securities with a carrying value of $ 56 million and $ 57 million at March 31, 2026 and December 31, 2025, respectively, were on deposit with regulatory authorities. Residential mortgage-backed securities (“RMBS”) include certain RMBS that are collateralized by residential mortgage loans and are neither expressly nor implicitly guaranteed by U.S. government agencies (“non-agency RMBS”). The Company’s non-agency RMBS include investments in securities backed by prime, Alt-A, and subprime loans, as follows (in millions): Allowance Gross Gross Amortized for Unrealized Unrealized Fair March 31, 2026 Cost (1) Credit Loss Gains Losses Value Prime $ 310 $ 1 $ 2 $ 14 $ 297 Alt-A 21 — 14 3 32 Subprime 7 — 4 — 11 Total non-agency RMBS $ 338 $ 1 $ 20 $ 17 $ 340 Allowance Gross Gross Amortized for Unrealized Unrealized Fair December 31, 2025 Cost (1) Credit Loss Gains Losses Value Prime $ 280 $ 2 $ 3 $ 13 $ 268 Alt-A 23 2 16 2 35 Subprime 7 — 4 — 11 Total non-agency RMBS $ 310 $ 4 $ 23 $ 15 $ 314 (1) Amortized cost, apart from carrying value for securities carried at fair value under the fair value option and trading securities. 18 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments The Company defines its exposure to non-agency RMBS as follows: • Prime loan-backed securities that are collateralized by mortgage loans made to the highest rated borrowers; • Alt-A loan-backed securities that are collateralized by mortgage loans made to borrowers who lack credit documentation or necessary requirements to obtain prime borrower rates; and • Subprime loan-backed securities that are collateralized by mortgage loans made to borrowers that have a FICO score of 660 or lower. Unrealized Losses on Debt Securities For debt securities in an unrealized loss position, management first assesses whether the Company has the intent to sell, or whether it is more likely than not it will be required to sell, the security before the amortized cost basis is fully recovered. If either criterion is met, the amortized cost is written down to fair value through net gains (losses) on derivatives and investments as an impairment. If neither criterion is met, the securities are further evaluated to determine if the cause of the decline in fair value resulted from credit losses or other factors, such as estimates about issuer operations and future earnings potential. There are inherent uncertainties in assessing the fair values assigned to the Company’s investments. The Company’s reviews of net present value and fair value involve several criteria including economic conditions, credit loss experience, other issuer-specific developments and estimated future cash flows. These assessments are based on the best available information at the time. Factors such as market liquidity, the widening of bid/ask spreads and a change in cash flow assumptions can contribute to future price volatility. If actual experience differs negatively from the assumptions and other considerations used in the Condensed Consolidated Financial Statements, unrealized losses currently reported in accumulated other comprehensive income (loss) may be recognized in the consolidated income statements in future periods. The Company currently has no intent to sell securities with unrealized losses considered to be temporary until they mature or recover in value and believes that it has the ability to do so. However, if the specific facts and circumstances surrounding an individual security, or the outlook for its industry sector change, the Company may sell the security prior to its maturity or recovery and realize a loss. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Accrued interest receivables are presented separate from the amortized cost basis of debt securities. Accrued interest receivables that are determined to be uncollectible are written off with a corresponding reduction to net investment income. Accrued interest written off was $ 1 million and nil for the three months ended March 31, 2026 and 2025, respectively. 19 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments The following table summarizes the gross unrealized losses of debt securities, fair value, and number of securities, aggregated by investment category and length of time that individual debt securities have been in a continuous loss position (dollars in millions): March 31, 2026 December 31, 2025 Less than 12 months Less than 12 months Gross Fair Value Gross Fair Value Unrealized # of Unrealized # of Losses securities Losses securities U.S. government securities $ 2 $ 335 23 $ 2 $ 68 16 Other government securities 3 116 26 1 48 7 Public utilities 22 1,083 137 7 419 44 Corporate securities 160 8,160 906 44 2,300 240 Residential mortgage-backed 5 162 63 2 43 21 Commercial mortgage-backed 5 632 85 2 163 30 Other asset-backed securities 34 2,747 240 16 673 69 Total temporarily impaired securities $ 231 $ 13,235 1,480 $ 74 $ 3,714 427 12 months or longer 12 months or longer Gross Fair Value Gross Fair Value Unrealized # of Unrealized # of Losses securities Losses securities U.S. government securities $ 863 $ 2,238 20 $ 849 $ 2,263 20 Other government securities 199 856 100 192 887 107 Public utilities 508 3,293 402 451 3,383 415 Corporate securities 2,095 11,164 1,431 1,998 12,130 1,502 Residential mortgage-backed 21 144 161 21 172 166 Commercial mortgage-backed 56 778 116 52 801 117 Other asset-backed securities 106 1,131 137 114 1,249 147 Total temporarily impaired securities $ 3,848 $ 19,604 2,367 $ 3,677 $ 20,885 2,474 Total Total Gross Gross Unrealized Fair # of Unrealized Fair # of Losses Value securities (1) Losses Value securities (1) U.S. government securities $ 865 $ 2,573 38 $ 851 $ 2,331 31 Other government securities 202 972 124 193 935 113 Public utilities 530 4,376 522 458 3,802 454 Corporate securities 2,255 19,324 2,224 2,042 14,430 1,706 Residential mortgage-backed 26 306 223 23 215 187 Commercial mortgage-backed 61 1,410 194 54 964 146 Other asset-backed securities 140 3,878 370 130 1,922 211 Total temporarily impaired securities $ 4,079 $ 32,839 3,695 $ 3,751 $ 24,599 2,848 (1) Certain securities contain multiple lots and fit the criteria of both aging groups. Debt securities in an unrealized loss position as of March 31, 2026, did not require an impairment recognized in earnings as (i) the Company did not intend to sell these debt securities, (ii) it is not more likely than not that the Company will be required to sell these securities before recovery of their amortized cost basis, and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. Based upon this evaluation, the Company believes it has the ability to generate adequate amounts of cash from normal operations to meet cash requirements with a reasonable margin of safety without requiring the sale of these securities. 20 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments As of March 31, 2026, unrealized losses associated with debt securities are primarily due to widening credit spreads or rising risk-free rates since purchase. As described below, the Company performed analyses of the financial performance of the underlying issues in an unrealized loss position and believes that recovery of the entire amortized cost of each such security is expected. Evaluation of Available-for-Sale Debt Securities for Credit Loss The credit loss evaluation for a debt security may consider one or more of the following: • the extent to which the fair value is below amortized cost; • changes in ratings; • whether a significant covenant has been breached; • assessments of the issuer’s ability to make scheduled debt payments based upon judgments related to its current and projected financial position, including whether it has filed or indicated a possibility of filing for bankruptcy, has missed or announced it intends to miss a scheduled debt service payment, or has experienced a specific material adverse change that may impair its creditworthiness; • the existence of, and realizable value of, any collateral backing the obligations; • the macro-economic and micro-economic outlooks for the issuer and its industry; • for asset-backed securities: includes an assessment of future estimated cash flows under expected and stress case scenarios to identify potential shortfalls in contractual payments. These estimated cash flows are developed using available performance indicators from the underlying assets, such as current and projected default or delinquency rates, levels of credit enhancement, current subordination levels, vintage, expected loss severity and other relevant characteristics; and • for mortgage-backed securities, credit losses are assessed using a cash flow model that estimates the cash flows on the underlying mortgages, using the security-specific collateral characteristics and transaction structure. The model estimates cash flows from the underlying mortgage loans and distributes those cash flows to various tranches of securities based on the transaction structure and any existing subordination and credit enhancements. The cash flow model incorporates actual cash flows on the mortgage-backed securities through the current period and then projects the remaining cash flows using a number of assumptions, including prepayment timing, default rates and loss severity. Specifically, for prime and Alt-A RMBS, the assumed default percentage is dependent on the severity of delinquency status, with foreclosures and real estate owned receiving higher rates, but also includes the currently performing loans. These estimates reflect a combination of data derived by third parties and internally developed assumptions. Where possible, this data is benchmarked against other third-party sources. In addition, these estimates are extrapolated along a default timing curve to estimate the total lifetime pool default rate. When a credit loss is determined to exist and the present value of cash flows expected to be collected is less than the amortized cost of the security, an allowance for credit loss is recorded along with a charge to net gains (losses) on derivatives and investments, limited by the amount that the fair value is less than amortized cost. Any remaining unrealized loss after recording the allowance for credit loss is the non-credit amount and is recorded to other comprehensive income. The allowance for credit loss for specific debt securities may be increased or reversed in subsequent periods due to changes in the assessment of the present value of cash flows that are expected to be collected. Any changes to the allowance for credit loss are recorded as a provision for (or reversal of) credit loss expense in net gains (losses) on derivatives and investments. 21 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments The roll-forward of the allowance for credit loss for available-for-sale securities by sector is as follows (in millions): Three Months Ended March 31, 2026 US government securities Other government securities Public utilities Corporate securities Residential mortgage-backed Commercial mortgage-backed Other asset-backed securities Total Balance at January 1, 2026 $ — $ — $ — $ — $ 4 $ — $ 7 $ 11 Additions for which credit loss was not previously recorded — — — 6 — — — 6 Changes for securities with previously recorded credit loss — — — — ( 1 ) — 28 27 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — — — — ( 18 ) ( 18 ) Reductions for securities disposed — — — — ( 2 ) — ( 7 ) ( 9 ) Securities intended/required to be sold before recovery of amortized cost basis — — — — — — — — Balance at March 31, 2026 (2) $ — $ — $ — $ 6 $ 1 $ — $ 10 $ 17 Three Months Ended March 31, 2025 US government securities Other government securities Public utilities Corporate securities Residential mortgage-backed Commercial mortgage-backed Other asset-backed securities Total Balance at January 1, 2025 $ — $ — $ — $ 8 $ 6 $ — $ 25 $ 39 Additions for which credit loss was not previously recorded — — — — — 1 — 1 Changes for securities with previously recorded credit loss — — — — — — 1 1 Additions for purchases of PCD debt securities (1) — — — — — — — — Reductions from charge-offs — — — — — — — — Reductions for securities disposed — — — — — — — — Securities intended/required to be sold before recovery of amortized cost basis — — — — — ( 1 ) — ( 1 ) Balance at March 31, 2025 (2) $ — $ — $ — $ 8 $ 6 $ — $ 26 $ 40 (1) Represents purchased credit-deteriorated ("PCD") fixed maturity available-for-sale securities. (2) Accrued interest receivable on debt securities totaled $ 519 million and $ 448 million as of March 31, 2026 and 2025, respectively, and was excluded from the determination of credit losses for the three months ended March 31, 2026 and 2025. 22 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments Net Investment Income The sources of net investment income were as follows (in millions): Three Months Ended March 31, 2026 2025 Debt securities (1) $ 472 $ 431 Equity securities (2) ( 59 ) 1 Mortgage loans 99 83 Policy loans 16 17 Limited partnerships 19 38 Other investment income 57 52 Total investment income excluding funds withheld assets 604 622 Investment expenses (3) ( 63 ) ( 94 ) Net investment income excluding funds withheld assets 541 528 Net investment income on funds withheld assets (see Note 8) 199 227 Net investment income $ 740 $ 755 (1) Includes changes in fair value gains (losses) on trading securities and includes $( 72 ) million and $( 10 ) million for the three months ended March 31, 2026 and 2025, respectively, related to the change in fair value for securities carried under the fair value option. (2) Includes changes in fair value of TPG common stock. See discussion above on our Long-term Strategic Partnership with TPG. (3) Includes expenses from consolidated variable interest entities, which includes changes in fair value of notes issued by those entities, of $( 16 ) million and $( 32 ) million for the three months ended March 31, 2026 and 2025, respectively. Unrealized gains (losses) included in investment income that were recognized on equity securities held were $( 64 ) million and $( 2 ) million for the three months ended March 31, 2026 and 2025, respectively. Net Gains (Losses) on Derivatives and Investments The following table summarizes net gains (losses) on derivatives and investments (in millions): Three Months Ended March 31, 2026 2025 Available-for-sale securities Realized gains on sale $ 7 $ 3 Realized losses on sale ( 9 ) ( 12 ) Credit loss income (expense) ( 8 ) — Credit loss income (expense) on mortgage loans ( 26 ) ( 11 ) Other (1) ( 11 ) ( 46 ) Net gains (losses) excluding derivatives and funds withheld assets ( 47 ) ( 66 ) Net gains (losses) on derivative instruments (see Note 5) 330 1,409 Net gains (losses) on derivatives and investments 283 1,343 Net gains (losses) on funds withheld reinsurance treaties (see Note 8) ( 159 ) ( 388 ) Total net gains (losses) on derivatives and investments $ 124 $ 955 (1) Includes the foreign currency gain or loss related to foreign denominated trust instruments supporting funding agreements. Net gains (losses) on funds withheld reinsurance treaties represents income (loss) from the sale of investments held in segregated funds withheld accounts in support of reinsurance agreements for which Jackson retains legal ownership of the underlying investments. These gains (losses) are increased or decreased by: • changes in the embedded derivative liability related to the Athene Life Re Ltd. ("Athene") funds withheld coinsurance agreement (the “Athene Reinsurance Transaction”), 23 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments • changes in the related funds withheld payable, as all economic performance of the investments held in the segregated accounts inure to the benefit of the reinsurers under the respective reinsurance agreements, and • amortization of the difference between book value and fair value of the investments as of the effective date of the reinsurance agreements. The aggregate fair value of securities sold at a loss for the three months ended March 31, 2026 and 2025 was $ 288 million and $ 669 million, which was approximately 94 % and 95 % of book value, respectively. Proceeds from sales of available-for-sale debt securities were $ 636 million and $ 934 million during the three months ended March 31, 2026 and 2025, respectively. Consolidated Variable Interest Entities ("VIEs") The Company concluded that the following entities are VIEs and that the Company is the primary beneficiary as it has both the power to direct the most significant activities of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. In each case, the Company’s exposure to loss is limited to the capital invested plus, in the cases of the limited liability companies ("LLCs") and the Private Equity Funds, unfunded capital commitments. Creditors of the consolidated VIEs do not have recourse to the general credit of the Company: • The Company funds affiliated LLCs to facilitate the issuance of collateralized loan obligations ("CLOs"). The Company's policy is to record the consolidation of VIEs on a one-month lag due to the timing of when information is available from the VIE. • Private Equity Funds VII – IX and Strategic Opportunity Fund I are limited partnership structures that invest the ownership capital in portfolios of various other limited partnership structures. Private Equity Fund IX was funded in August 2025 and Strategic Opportunity Fund I was funded in June 2025. • PPM Investment Grade Private Credit Fund is a private fund organized as a series of a Delaware LLC that invests primarily in fixed rate, privately issued, investment grade instruments. The series was funded in January 2026. Asset and liability information for the consolidated VIEs included on the Condensed Consolidated Balance Sheets are as follows (in millions): March 31, 2026 December 31, 2025 Assets Debt securities, at fair value under fair value option $ 2,650 $ 2,698 Equity securities 8 6 Other invested assets 1,083 979 Cash and cash equivalents 176 154 Other assets 71 51 Total assets $ 3,988 $ 3,888 Liabilities Notes issued by consolidated VIEs, at fair value under fair value option $ 2,543 $ 2,578 Other liabilities 323 258 Total other liabilities 2,866 2,836 Total liabilities $ 2,866 $ 2,836 Equity Noncontrolling interests $ 404 $ 389 24 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments Unconsolidated VIEs The Company has concluded the following entities are VIEs but does not consolidate them. Based on analysis of the limited partnerships ("LPs"), LLCs and the mutual funds, the Company is not the primary beneficiary of the VIE because the Company lacks the power to direct the activities of the VIE that most significantly impact the VIE's performance or lacks the obligation to absorb losses or the right to receive benefits that could potentially be significant to the entities, or lacks both. • The carrying amounts of the Company’s investments in certain LPs and LLCs are recognized in other invested assets on the Condensed Consolidated Balance Sheets. Unfunded capital commitments for these investments are detailed in Note 16 of these Notes to Condensed Consolidated Financial Statements. The Company’s exposure to loss was limited to $ 2,784 million and $ 2,709 million as of March 31, 2026 and December 31, 2025, respectively, representing the aggregate capital invested and unfunded capital commitments related to the LPs and LLCs at those dates. The capital invested in an LP or LLC equals the original capital contributed, increased for additional capital contributed after the initial investment, and reduced for any returns of capital from the LP or LLC. LPs and LLCs are carried at fair value. • The Company's investments in certain mutual funds are recognized in equity securities on the Condensed Consolidated Balance Sheets and were $ 18 million and $ 21 million as of March 31, 2026 and December 31, 2025, respectively. The Company’s maximum exposure to loss on these mutual funds is limited to the amortized cost for these investments. The Company makes investments in structured debt securities issued by VIEs for which it is not the manager. These structured debt securities include RMBS, Commercial Mortgage-Backed Securities ("CMBS"), and Asset-Backed Securities ("ABS"). The Company does not consolidate the securitization trusts utilized in these transactions because it does not have the power to direct the activities that most significantly impact the economic performance of these securitization trusts. The Company does not consider its continuing involvement with these VIEs to be significant because it either invests in securities issued by the VIE and was not involved in the design of the VIE or no transfers have occurred between the Company and the VIE. The Company’s maximum exposure to loss on these structured debt securities is limited to the amortized cost of these investments. The Company does not have any further contractual obligations to the VIE. The Company recognizes the variable interest in these VIEs at fair value on the Condensed Consolidated Balance Sheets. Commercial and Residential Mortgage Loans The following table shows commercial mortgage loans, residential mortgage loans, and the respective accrued interest thereon (in millions): March 31, 2026 December 31, 2025 Commercial mortgage loans (1) $ 9,137 $ 8,957 Accrued interest receivable on commercial mortgage loans 35 34 Residential mortgage loans (2) 1,307 1,254 Accrued interest receivable on residential mortgage loans 13 13 (1) Net of an allowance for credit losses of $ 137 million and $ 117 million at each date, respectively. (2) Net of an allowance for credit losses of $ 22 million and $ 16 million at each date, respectively. At March 31, 2026, commercial mortgage loans were collateralized by properties located in 36 states, the District of Columbia, and Europe, while residential mortgage loans were collateralized by properties located in 49 states, the District of Columbia, Mexico, and Europe. 25 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments Evaluation for Credit Losses on Mortgage Loans The Company reviews mortgage loans that are not carried at fair value under the fair value option on a quarterly basis to estimate the ACL with changes in the ACL recorded in net gains (losses) on derivatives and investments. Apart from an ACL recorded on individual mortgage loans where the borrower is experiencing financial difficulties, the Company records an ACL on the pool of mortgage loans based on lifetime expected credit losses. The Company utilizes a third-party forecasting model to estimate lifetime expected credit losses at a loan level for mortgage loans. The model forecasts net operating income and property values for the economic scenario selected. The debt service coverage ratios (“DSCR”) and loan to values (“LTV”) are calculated over the forecastable period by comparing the projected net operating income and property valuations to the loan payment and principal amounts of each loan. The model utilizes historical mortgage loan performance based on DSCRs and LTV to derive probability of default and expected losses based on the economic scenario that is similar to the Company’s expectations of economic factors such as unemployment, gross domestic product growth, and interest rates. The Company determined the forecastable period to be reasonable and supportable for a period of two years beyond the end of the reporting period. Over the following one-year period, the model reverts to the historical performance of the portfolio for the remainder of the contractual term of the loans. In cases where the Company does not have an appropriate length of historical performance, the relevant historical rate from an index or the lifetime expected credit loss calculated from the model may be used. Unfunded commitments are included in the model and an ACL is determined accordingly. Credit loss estimates are pooled by property type and the Company does not include accrued interest in the determination of ACL. For individual loans or for types of loans for which the third-party model is deemed not suitable, the Company utilizes relevant current market data, industry data, and publicly available historical loss rates to calculate an estimate of the lifetime expected credit loss. Mortgage loans on real estate deemed uncollectible are charged against the ACL, and subsequent recoveries, if any, are credited to the ACL, limited to the aggregate of amounts previously charged-off and expected to be charged-off. Mortgage loans on real estate are presented net of the ACL on the Condensed Consolidated Balance Sheets. The following table provides the change in the allowance for credit losses in the Company’s mortgage loan portfolios (in millions): Three Months Ended March 31, 2026 Apartment Hotel Office Retail Warehouse Other Residential Mortgage Total Balance at January 1, 2026 $ 32 $ 11 $ 28 $ 17 $ 27 $ 2 $ 16 $ 133 Charge offs, net of recoveries ( 1 ) — ( 4 ) — — — — ( 5 ) Reductions for mortgages disposed — — — — — — — — Additions from purchase of PCD mortgage loans — — — — — — — — Provision (release) ( 8 ) ( 7 ) 32 13 ( 4 ) ( 1 ) 6 31 Balance at March 31, 2026 (1) (2) $ 23 $ 4 $ 56 $ 30 $ 23 $ 1 $ 22 $ 159 Three Months Ended March 31, 2025 Apartment Hotel Office Retail Warehouse Other Residential Mortgage Total Balance at January 1, 2025 $ 23 $ 7 $ 44 $ 19 $ 20 $ 3 $ 5 $ 121 Charge offs, net of recoveries — — ( 6 ) — — — — ( 6 ) Reductions for mortgages disposed — — — — — — — — Additions from purchase of PCD mortgage loans — — — — — — — — Provision (release) 5 — 2 — — ( 1 ) 9 15 Balance at March 31, 2025 (1) (2) $ 28 $ 7 $ 40 $ 19 $ 20 $ 2 $ 14 $ 130 (1) Accrued interest receivable totaled $ 48 million and $ 42 million as of March 31, 2026 and 2025, respectively, and was excluded from the determination of credit losses. (2) Accrued interest amounting to nil and nil was written off as of March 31, 2026 and 2025, respectively, relating to loans that were greater than 90 days delinquent or in the process of foreclosure. 26 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments The Company’s mortgage loans that are current and in good standing are accruing interest. Interest is not accrued on loans greater than 90 days delinquent and in process of foreclosure, when deemed uncollectible. Delinquency status is determined from the date of the first missed contractual payment. The following table provides information about our residential mortgage loans in process of foreclosure (in millions): March 31, 2026 December 31, 2025 Recorded investment (1) $ 27 $ 38 Unpaid principal balance 30 45 Related loan allowance — 1 Average recorded investment 27 29 Investment income recognized — 1 (1) At March 31, 2026 and December 31, 2025, includes $ 4 million and $ 4 million, respectively, of loans in process of foreclosure, all of which are loans supported with insurance or other guarantees provided by various governmental programs. The following tables provide information about the credit quality with vintage year and category of mortgage loans (dollars in millions): March 31, 2026 2026 2025 2024 2023 2022 Prior Revolving Loans Total % of Total Commercial mortgage loans Loan to value ratios (1) : Less than 70% $ 476 $ 1,126 $ 507 $ 473 $ 420 $ 4,448 $ — $ 7,450 81 % 70% - 80% — 247 130 44 180 700 — 1,301 14 % 80% - 100% — 40 1 25 46 132 — 244 3 % Greater than 100% — — 2 — 55 85 — 142 2 % Total commercial mortgage loans 476 1,413 640 542 701 5,365 — 9,137 100 % Debt service coverage ratios (2) : Greater than 1.20x 475 1,320 612 486 586 4,841 — 8,320 91 % 1.00x - 1.20x — 43 24 48 55 379 — 549 6 % Less than 1.00x — — — — 51 144 — 195 2 % Non-income producing properties 1 50 4 8 9 1 — 73 1 % Total commercial mortgage loans 476 1,413 640 542 701 5,365 — 9,137 100 % Residential mortgage loans Performing 27 589 202 10 13 414 — 1,255 96 % Nonperforming — 2 4 9 8 29 — 52 4 % Total residential mortgage loans 27 591 206 19 21 443 — 1,307 100 % Total mortgage loans $ 503 $ 2,004 $ 846 $ 561 $ 722 $ 5,808 $ — $ 10,444 100 % (1) The loan to value ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan. (2) The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. 27 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments December 31, 2025 2025 2024 2023 2022 2021 Prior Revolving Loans Total % of Total Commercial mortgage loans Loan to value ratios (1) : Less than 70% $ 1,140 $ 508 $ 521 $ 466 $ 345 $ 4,296 $ — $ 7,276 81 % 70% - 80% 206 129 62 221 353 316 — 1,287 14 % 80% - 100% — — 25 46 24 151 — 246 3 % Greater than 100% — 2 — 56 — 90 — 148 2 % Total commercial mortgage loans 1,346 639 608 789 722 4,853 — 8,957 100 % Debt service coverage ratios (2) : Greater than 1.20x 1,313 615 538 594 434 4,591 — 8,085 90 % 1.00x - 1.20x 33 24 70 145 174 231 — 677 8 % Less than 1.00x — — — 50 114 31 — 195 2 % Total commercial mortgage loans 1,346 639 608 789 722 4,853 — 8,957 100 % Residential mortgage loans Performing 487 223 17 17 71 375 — 1,190 95 % Nonperforming — 4 16 20 3 21 — 64 5 % Total residential mortgage loans 487 227 33 37 74 396 — 1,254 100 % Total mortgage loans $ 1,833 $ 866 $ 641 $ 826 $ 796 $ 5,249 $ — $ 10,211 100 % (1) The loan to value ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan. (2) The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. Accruing Loans (1) March 31, 2026 Current 30-89 Days Past Due (2) 90 Days or Greater Past Due (2) Non-accrual Loans (1) Total Loans (1) Non-accrual Loans with No Allowance (1) Interest Income on Non-accrual Loans Apartment $ 3,189 $ 6 $ — $ 16 $ 3,211 $ — $ — Hotel 762 — — — 762 — — Office 1,056 10 — 83 1,149 — — Retail 1,652 — — — 1,652 — — Warehouse 2,136 — — — 2,136 — — Other 364 — — — 364 — — Total commercial 9,159 16 — 99 9,274 — — Residential (2) 1,222 51 21 35 1,329 — — Total $ 10,381 $ 67 $ 21 $ 134 10,603 $ — $ — ACL ( 159 ) Total with ACL $ 10,444 28 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments Accruing Loans (1) December 31, 2025 Current 30-89 Days Past Due (2) 90 Days or Greater Past Due (2) Non-accrual Loans (1) Total Loans (1) Non-accrual Loans with No Allowance (1) Interest Income on Non-accrual Loans Apartment $ 2,866 $ — $ — $ — $ 2,866 $ — $ — Hotel 789 — — — 789 — — Office 1,062 — — 109 1,171 — — Retail 1,664 — — — 1,664 — — Warehouse 2,217 — — — 2,217 — — Other 367 — — — 367 — — Total commercial 8,965 — — 109 9,074 — — Residential (2) 1,124 69 16 61 1,270 — 2 Total $ 10,089 $ 69 $ 16 $ 170 $ 10,344 $ — $ 2 ACL ( 133 ) Total with ACL $ 10,211 (1) Amortized cost or fair value for loans carried at fair value under the fair value option. (2) At March 31, 2026 and December 31, 2025, includes $ 15 million and $ 19 million, respectively, of loans 30-89 days past due and $ 21 million and $ 16 million, respectively, of loans 90 days or greater past due and supported with insurance or other guarantees provided by various governmental programs. The following table provides information about the mortgage loans modified during the periods indicated to borrowers experiencing financial difficulty (dollars in millions): Term Extension Amortized Cost Basis Percent of Total Class Three Months Ended March 31, 2026 Commercial mortgage loans $ 10 0.11 % Three Months Ended March 31, 2025 Commercial mortgage loans $ — — % As of March 31, 2026, the above modified loans had $ 8 million unfunded commitments. The following table describes the financial effect of the modifications made to the loans noted above: Term Extension Financial Effect Three Months Ended March 31, 2026 Commercial mortgage loans Granted extension of term for 42 months and rate converted from variable to fixed. 29 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments The Company closely monitors the performance of the loans that are modified to borrowers experiencing financial difficulty to understand the effectiveness of its modification efforts. The following table depicts the performance of loans that have been modified in the last 12 months (in millions): Payment Status (Amortized Cost Basis) Current 30-89 Days Past Due 90+ Days Past Due March 31, 2026 Commercial mortgage loans $ — $ 10 $ — March 31, 2025 Commercial mortgage loans $ — $ — $ — As of March 31, 2026 and 2025, stressed mortgage loans for which the Company is dependent, or expects to be dependent, on the underlying property to satisfy repayment were $ 24 million and $ 29 million, respectively. Policy Loans Policy loans are loans the Company issues to contract holders that use the cash surrender value of their life insurance policy or annuity contract as collateral. At March 31, 2026 and December 31, 2025, $ 3.6 billion and $ 3.5 billion of these loans were carried at fair value, which the Company believes is equal to unpaid principal balances, plus accrued investment income. At both March 31, 2026 and December 31, 2025, the Company had $ 0.9 billion of policy loans not held as collateral for reinsurance, which were carried at the unpaid principal balances. Other Invested Assets Other invested assets primarily include investments in: • Federal Home Loan Bank of Indianapolis ("FHLBI") capital stock, which is carried at cost and adjusted for any impairment. At both March 31, 2026 and December 31, 2025, FHLBI capital stock had a carrying value of $ 119 million; • limited partnerships (“LPs”), which are carried at values determined by using the proportion of the Company’s investment in each fund (Net Asset Value (“NAV”) equivalent) as a practical expedient for fair value, and generally are recorded on a three-month lag, with changes in value included in net investment income. At March 31, 2026 and December 31, 2025, investments in LPs had carrying values of $ 2.9 billion and $ 2.8 billion, respectively; and • real estate, which is carried at the lower of depreciated cost or fair value and real estate occupied by the Company is carried at depreciated cost. At March 31, 2026 and December 31, 2025, real estate totaling $ 231 million and $ 230 million, respectively, included foreclosed properties with a book value of $ 22 million and $ 20 million at March 31, 2026 and December 31, 2025, respectively. Securities Lending The Company has entered into securities lending agreements with agent banks whereby blocks of securities are loaned to third parties, primarily major brokerage firms. As of March 31, 2026 and December 31, 2025, the estimated fair value of loaned securities was $ 52 million and $ 34 million, respectively. The agreements require a minimum of 102 % of the fair value of the loaned securities to be held as collateral, calculated daily. To further minimize the credit risks related to these programs, the financial condition of counterparties is monitored on a regular basis. At March 31, 2026 and December 31, 2025, cash collateral received in the amount of $ 54 million and $ 35 million, respectively, was invested by the agent banks and included in cash and cash equivalents of the Company. A securities lending payable for the overnight and continuous loans is included in liabilities in the amount of cash collateral received. Securities lending transactions are used to generate income. Income and expenses associated with these transactions are reported as net investment income. 30 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments Repurchase Agreements The Company routinely enters into repurchase agreements whereby the Company agrees to sell and repurchase securities. These agreements are accounted for as financing transactions, with the assets and associated liabilities included in the Condensed Consolidated Balance Sheets. At March 31, 2026 and December 31, 2025, the outstanding repurchase agreement balance was $ 0.5 billion and $ 1.0 billion, respectively, having maturities within 30 days, and was included within repurchase agreements and securities lending payable in the Condensed Consolidated Balance Sheets. These repurchase agreements were collateralized with U.S. Treasury securities and corporate securities of $ 0.5 billion and $ 1.0 billion, respectively, at March 31, 2026 and December 31, 2025. In the event of a decline in the fair value of the pledged collateral under these agreements, the Company may be required to transfer cash or additional securities as pledged collateral. Interest expense totaled $ 2 million and $ 12 million for the three months ended March 31, 2026 and 2025, respectively, and is included within net investment income. Collateral Upgrade Transactions During the first quarter of 2024, Jackson executed certain paired repurchase and reverse repurchase transactions totaling $ 1.5 billion pursuant to master repurchase agreements with participating bank counterparties. Under these transactions, the Company lends securities ( e.g. , corporate debt securities) to bank counterparties in exchange for U.S. Treasury securities that the Company then uses to provide as collateral. The paired repurchase and reverse repurchase transactions are settled on a net basis. As a result, there was no cash exchanged at initiation of these agreements. The paired transactions are reported net within the Condensed Consolidated Balance Sheets. These transactions are evergreen and require at least 150 -days' notice prior to termination. At both March 31, 2026 and December 31, 2025, the fair value of the U.S. treasuries received was $ 1.5 billion, collateralized with corporate securities with a fair value of $ 1.6 billion. Subsequently, the Company provided these U.S. Treasury securities as collateral for derivative trades, and they are included as part of the derivative collateral disclosures. In the event of a decline in the fair value of the pledged collateral under these agreements, the Company may be required to transfer cash or additional securities as pledged collateral. Gross interest income of $ 14 million and $ 16 million and gross interest expense of $ 16 million and $ 19 million for the three months ended March 31, 2026 and 2025, respectively, are included within net investment income. 31 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments 5. Derivative Instruments The Company’s business model includes the acceptance, monitoring and mitigation of risk. Specifically, the Company considers, among other factors, exposures to equity market and interest rate movements, foreign exchange rates and other asset or liability prices. The Company uses derivative instruments to mitigate or reduce these risks in accordance with established policies and goals. The Company’s derivative holdings, while effective in managing defined risks, are not structured to meet accounting requirements to be designated as hedging instruments. As a result, freestanding derivatives are carried at fair value with changes recorded in net gains (losses) on derivatives and investments. During the third quarter of 2025, the Company began utilizing derivative instruments to economically hedge the equity market exposure related to the Company’s non-qualified voluntary deferred compensation plans. These derivative instruments are not designated as accounting hedges and are carried at fair value with gains or losses reported as a component of operating costs and other expenses, net of deferrals in the Condensed Consolidated Income Statement. See Item 8. Financial Statements and Supplementary Data - Note 20 - Benefit Plans of the Notes to Consolidated Financial Statements included in our 2025 Annual Report for further details on our non-qualified deferred compensation plans. A summary of the aggregate contractual or notional amounts and fair values of the Company’s freestanding and embedded derivative instruments are as follows (in millions): March 31, 2026 Contractual/ Assets Liabilities Net Notional Fair Fair Fair Value Amount (1) Value Value Asset (Liability) Freestanding derivatives Cross-currency swaps $ 1,595 $ 140 $ 100 $ 40 Equity index futures (2) 45,209 — — — Equity index put options 20,000 361 — 361 Interest rate swaps - cleared (2) 3,695 — — — Interest rate futures (2) 19,195 — — — Total return swaps 3,516 69 37 32 Bond forwards 8,284 112 89 23 Total freestanding derivatives 101,494 682 226 456 Embedded derivatives Fixed index annuity embedded derivatives (3) N/A — 818 ( 818 ) Registered index linked annuity embedded derivatives (3) N/A — 5,499 ( 5,499 ) Total embedded derivatives N/A — 6,317 ( 6,317 ) Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps 158 12 — 12 Cross-currency forwards 754 7 12 ( 5 ) Funds withheld embedded derivative (4) N/A 1,765 — 1,765 Total derivatives related to funds withheld under reinsurance treaties 912 1,784 12 1,772 Total $ 102,406 $ 2,466 $ 6,555 $ ( 4,089 ) (1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. (2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. (3) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The non-performance risk adjustment is included in the balance above. (4) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. 32 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments December 31, 2025 Contractual/ Assets Liabilities Net Notional Fair Fair Fair Value Amount (1) Value Value Asset (Liability) Freestanding derivatives Cross-currency swaps $ 1,379 $ 133 $ 114 $ 19 Equity index futures (2) 43,905 — — — Equity index put options 16,500 114 — 114 Interest rate swaps - cleared (2) 2,485 — — — Interest rate futures (2) 21,874 — — — Total return swaps 3,544 22 43 ( 21 ) Bond forwards 8,143 161 78 83 Total freestanding derivatives 97,830 430 235 195 Embedded derivatives Fixed index annuity embedded derivatives (3) N/A — 863 ( 863 ) Registered index linked annuity embedded derivatives (3) N/A — 6,043 ( 6,043 ) Total embedded derivatives N/A — 6,906 ( 6,906 ) Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps 158 11 1 10 Cross-currency forwards 1,133 7 21 ( 14 ) Funds withheld embedded derivative (4) N/A 1,752 — 1,752 Total derivatives related to funds withheld under reinsurance treaties 1,291 1,770 22 1,748 Total $ 99,121 $ 2,200 $ 7,163 $ ( 4,963 ) (1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures, forwards, and options represents the market exposure of open positions. (2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. (3) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The non-performance risk adjustment is included in the balance above. (4) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. 33 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments The following table reflects the results of the Company’s derivatives, including gains (losses) and change in fair value of freestanding derivative instruments and embedded derivatives (in millions): Three Months Ended March 31, 2026 2025 Derivatives excluding funds withheld under reinsurance treaties and non-qualified voluntary deferred compensation plan Cross-currency swaps $ 18 $ 27 Equity index futures ( 433 ) 147 Equity index put options 23 108 Interest rate swaps 24 28 Interest rate futures ( 106 ) 476 Total return swaps 107 112 Bond forwards ( 67 ) 115 Fixed index annuity embedded derivatives 6 ( 1 ) Registered index linked annuity embedded derivatives 758 397 Total net gains (losses) on derivative instruments excluding derivative instruments related to funds withheld under reinsurance treaties 330 1,409 Derivatives related to funds withheld under reinsurance treaties Cross-currency swaps 2 1 Cross-currency forwards 2 ( 18 ) Funds withheld embedded derivative 14 ( 201 ) Total net gains (losses) on derivative instruments related to funds withheld under reinsurance treaties 18 ( 218 ) Total net gains (losses) on derivative instruments including derivative instruments related to funds withheld under reinsurance treaties $ 348 $ 1,191 Derivatives related to non-qualified voluntary deferred compensation plan Equity index futures $ ( 6 ) $ — Total return swaps ( 3 ) — Total operating costs and other expenses related to non-qualified voluntary deferred compensation plan $ ( 9 ) $ — All the Company’s trade agreements for freestanding, over-the-counter derivatives contain credit downgrade provisions that allow a party to assign or terminate derivative transactions if the counterparty’s credit rating declines below an established limit. At March 31, 2026 and December 31, 2025, the fair value of the Company’s net non-cleared, over-the-counter derivative assets by counterparty were $ 209 million and $ 151 million, respectively, and held collateral was $ 487 million and $ 130 million, respectively, related to these agreements. At March 31, 2026 and December 31, 2025, the fair value of the Company’s net non-cleared, over-the-counter derivative liabilities by counterparty were $ 92 million and $ 237 million, respectively, and provided collateral was $ 119 million and $ 295 million, respectively, related to these agreements. If all of the downgrade provisions had been triggered at March 31, 2026 and December 31, 2025, in aggregate, the Company would have had to disburse $ 278 million and nil , respectively, and would have been allowed to claim $ 27 million and $ 79 million, respectively. The Company pledged collateral of $ 1,625 million and $ 1,403 million as of March 31, 2026 and December 31, 2025, respectively, for initial margin related to uncleared margin for over-the-counter derivatives and exchange-traded futures. Variation margin on exchange traded futures is settled through the netting of cash paid/received for variation margin against the fair value of the trades. 34 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments The Company purchases equity options for which option premium payments are deferred (deferred premium options). The deferred premiums, along with interest incurred thereon, are payable at contract termination. During three months ended March 31, 2026 and 2025, the Company deferred option premiums totaling $ 223 million and nil , respectively. The purchase of these options is a non-cash transaction. Upon maturity, payment of the deferred premium is reported as a cash flow from financing activities. Offsetting Assets and Liabilities The Company’s derivative instruments, repurchase agreements and securities lending agreements are subject to master netting arrangements and collateral arrangements. A master netting arrangement with a counterparty creates a right of offset for amounts due to and due from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company recognizes amounts subject to master netting arrangements on a gross basis within the Condensed Consolidated Balance Sheets. The following tables present the gross and net information about the Company’s financial instruments subject to master netting arrangements (in millions): March 31, 2026 Gross Amounts Recognized Gross Amounts Offset in the Condensed Consolidated Balance Sheets Net Amounts Presented in the Condensed Consolidated Balance Sheets Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets Financial Instruments (1) Cash Collateral Securities Collateral (2) Net Amount Financial Assets: Freestanding derivative assets $ 701 $ — $ 701 $ 492 $ 159 $ 48 $ 2 Financial Liabilities: Freestanding derivative liabilities $ 238 $ — $ 238 $ 146 $ 4 $ 55 $ 33 Derivative deferred premium payable 346 — 346 346 — — — Securities lending 54 — 54 — 54 — — Repurchase agreements 451 — 451 — — 451 — Repurchase agreements - collateral upgrade 1,482 ( 1,482 ) — — — — — Total financial liabilities $ 2,571 $ ( 1,482 ) $ 1,089 $ 492 $ 58 $ 506 $ 33 (1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. (2) Excludes initial margin amounts for exchange-traded derivatives. 35 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments December 31, 2025 Gross Amounts Recognized Gross Amounts Offset in the Condensed Consolidated Balance Sheets Net Amounts Presented in the Condensed Consolidated Balance Sheets Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets Financial Instruments (1) Cash Collateral Securities Collateral (2) Net Amount Financial Assets: Freestanding derivative assets $ 448 $ — $ 448 $ 297 $ 73 $ 53 $ 25 Financial Liabilities: Freestanding derivative liabilities $ 257 $ — $ 257 $ 20 $ 12 $ 221 $ 4 Derivative deferred premium payable 277 — 277 277 — — — Securities lending 35 — 35 — 35 — — Repurchase agreements 1,001 — 1,001 — — 1,001 — Repurchase agreements - collateral upgrade 1,498 ( 1,498 ) — — — — — Total financial liabilities $ 3,068 $ ( 1,498 ) $ 1,570 $ 297 $ 47 $ 1,222 $ 4 (1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. (2) Excludes initial margin amounts for exchange-traded derivatives. In the above tables, the amounts of assets or liabilities presented in the Company’s Condensed Consolidated Balance Sheets are offset first by financial instruments that have the right of offset under master netting or similar arrangements with any remaining amount reduced by the amount of cash and securities collateral. The actual amount of collateral may be greater than amounts presented in the tables. The above tables exclude: • net embedded derivative liabilities of $ 6,317 million and $ 6,906 million as of March 31, 2026 and December 31, 2025, respectively, as these derivatives are not subject to master netting arrangements; and • the funds withheld embedded derivative asset (liability) of $ 1,765 million and $ 1,752 million at March 31, 2026 and December 31, 2025, respectively. 36 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements 6. Fair Value Measurements The following table summarizes the fair value and carrying value of the Company’s financial instruments (in millions): March 31, 2026 December 31, 2025 Carrying Value Fair Value Carrying Value Fair Value Assets Debt securities (1) $ 51,948 $ 51,948 $ 50,791 $ 50,791 Equity securities 243 243 172 172 Mortgage loans (1) 10,444 10,188 10,211 9,948 Limited partnerships 2,896 2,896 2,836 2,836 Policy loans (1) 4,431 4,431 4,426 4,426 Freestanding derivative instruments 701 701 448 448 FHLBI capital stock 119 119 119 119 Cash and cash equivalents 5,539 5,539 5,704 5,704 Reinsurance recoverable on market risk benefits 121 121 118 118 Market risk benefit assets 6,701 6,701 7,867 7,867 Separate account assets 223,452 223,452 236,496 236,496 Liabilities Annuity reserves (2) 47,000 44,683 45,965 45,458 Market risk benefit liabilities 3,971 3,971 3,754 3,754 Guaranteed investment contracts and funding agreements (3) 11,141 10,933 11,021 11,077 Funds withheld payable under reinsurance treaties (1) 14,511 14,511 14,960 14,960 Long-term debt 2,027 1,831 2,030 1,877 Securities lending payable (4) 54 54 35 35 Freestanding derivative instruments 238 238 257 257 Notes issued by consolidated VIEs 2,543 2,543 2,578 2,578 Repurchase agreements (4) 451 451 1,001 1,001 FHLB advances (5) — — — — Separate account liabilities 223,452 223,452 236,496 236,496 (1) Includes items carried at fair value under the fair value option and trading securities included as a component of debt securities. (2) Annuity reserves exclude contracts classified as insurance contracts. (3) Included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets. (4) Included as a component of repurchase agreements and securities lending payable on the Condensed Consolidated Balance Sheets. (5) Included as a component of other liabilities on the Condensed Consolidated Balance Sheets. The following is a discussion of the methodologies used to determine fair values of the financial instruments measured on a recurring basis reported in the following tables. Debt and Equity Securities The fair values for debt and equity securities are determined using information available from independent pricing services, broker-dealer quotes, or internally derived estimates. Priority is given to publicly available prices from independent sources, when available. Securities for which the independent pricing service does not provide a quotation are either submitted to independent broker-dealers for prices or priced internally. Typical inputs used by these three pricing methods include reported trades, benchmark yields, credit spreads, liquidity premiums and/or estimated cash flows based on default and prepayment assumptions. 37 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements • Independent pricing services: As a result of typical trading volumes and the lack of specific quoted market prices for most debt securities, independent pricing services will normally derive the security prices through recently reported trades for identical or similar securities, making adjustments through the reporting date based upon available market observable information as outlined above. If there are no recently reported trades, the independent pricing services and broker-dealers may use matrix or pricing model processes to develop a security price where future cash flow expectations are developed based upon collateral performance and discounted at relevant market rates. On an ongoing basis, the Company reviews the independent pricing services’ valuation methodologies and related inputs and evaluates the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy distribution based upon trading activity and the observability of inputs. Based on the results of this evaluation, each price is classified into Level 1, 2, or 3. Most prices provided by independent pricing services are classified into Level 2 due to their use of market observable inputs. • Broker-dealer quotes: Certain securities are priced using broker-dealer quotes, which may utilize proprietary inputs and models. The majority of these quotes are non-binding. These securities are classified as Level 3 in the fair value hierarchy. • Internally derived estimates: These fair value estimates may incorporate Level 2 and Level 3 inputs, as defined below, and are generally derived using expected future cash flows, discounted at market interest rates available from market sources based on the credit quality and duration of the instrument. For securities that may not be reliably priced using these internally developed pricing models, a fair value may be estimated using indicative market prices. These prices are indicative of an exit price, but the assumptions used to establish the fair value may not be observable or corroborated by market observable information and, therefore, represent Level 3 inputs. For those securities that were internally valued at March 31, 2026 and December 31, 2025, the pricing model used by the Company utilizes current spread levels of similarly rated securities to determine the market discount rate for the security. Furthermore, appropriate risk premiums for illiquidity and non-performance are incorporated in the discount rate. Cash flows, as estimated by the Company using issuer-specific default statistics and prepayment assumptions, are discounted to determine an estimated fair value. The Company performs an analysis on the prices and credit spreads received from third parties to ensure that the prices represent a reasonable estimate of the fair value. This process involves quantitative and qualitative analysis and is overseen by investment and accounting professionals. Examples of procedures performed include initial and ongoing review of third-party pricing service methodologies, review of pricing statistics and trends, back testing recent trades and monitoring of trading volumes. In addition, the Company considers whether prices received from independent broker-dealers represent a reasonable estimate of fair value using internal and external cash flow models, which are developed based on spreads and, when available, market indices. As a result of this analysis, if the Company determines there is a more appropriate fair value based upon the available market data, the price received from the third party may be adjusted accordingly. Included in the pricing of asset-backed securities are estimates of the rate of future prepayments of principal over the remaining life of the securities. Such estimates are derived based on the characteristics of the underlying structure and prepayment assumptions believed to be relevant for the underlying collateral. Actual prepayment experience may vary from these estimates. Certain of the Company’s equity securities are subject to sale restrictions. Where these restrictions are not a characteristic of the asset, they are not considered when determining the fair value of the securities. Limited Partnerships Fair values for limited partnership interests, which are included in other invested assets, are generally determined using the proportion of the Company’s investment in the value of the net assets of each fund (“NAV equivalent”) as a practical expedient for fair value, and generally are recorded on a three-month lag. No adjustments to these amounts were deemed necessary at March 31, 2026 and December 31, 2025. As a result of using that practical expedient, limited partnership interests are not classified in the fair value hierarchy. 38 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements The Company’s limited partnership interests are not redeemable, and distributions received are generally the result of liquidation of the underlying assets of the partnerships. The Company generally has the ability under the partnership agreements to sell its interest to another limited partner with the prior written consent of the general partner. In cases when the Company expects to sell the limited partnership interest, the estimated sales price is used to determine the fair value rather than the practical expedient. Limited partnership interests expected to be sold are classified as Level 2 in the fair value hierarchy. In cases when a limited partnership’s financial statements are unavailable and a NAV equivalent is not available or practical, the fair value may be based on an internally developed model or provided by the general partner as determined using private transactions, information obtained from the primary co-investor or underlying company, or financial metrics provided by the lead sponsor. These investments are classified as Level 3 in the fair value hierarchy. Policy Loans Policy loans are funds provided to policyholders in return for a claim on their policies' values. They are repaid upon repayment, death or surrender, and there is only one market price at which the loans can be settled – the then current carrying value. The loans are limited to, and fully collateralized by, the cash surrender value of the underlying policy. The nature of policy loans is to have a negligible default risk. Policy loans do not have a stated maturity, and the balances and accrued interest are repaid either by the policyholder or with proceeds from the policy. Due to the collateralized nature of policy loans and unpredictable timing of payments, the Company believes the carrying value of policy loans approximates fair value. The reinsurance related component of policy loans at fair value under the fair value option has been classified as Level 3 within the fair value hierarchy. Freestanding Derivative Instruments Freestanding derivative instruments are reported at fair value, which reflects the estimated amounts, net of payment accruals, that the Company would receive or pay upon sale or termination of the contracts at the reporting date. Changes in fair value are included in net gains (losses) on derivatives and investments. Freestanding derivatives priced using third-party pricing services incorporate inputs that are observable in the market. Inputs used to value derivatives include interest rate swap curves, credit spreads, interest rates, counterparty credit risk, equity volatility and equity index levels. Freestanding derivative instruments classified as: • Level 1 include futures, which are traded on active exchanges. • Level 2 include interest rate swaps, cross currency swaps, credit default swaps, total return swaps, bond forwards, put-swaptions and certain equity index call and put options. These derivative valuations are determined by third-party pricing services using pricing models with inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. • Level 3 include interest rate contingent options that are valued by third-party pricing services utilizing significant unobservable inputs. Cash and Cash Equivalents Cash and cash equivalents primarily include money market instruments and bank deposits. Cash equivalents also include all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase. Certain money market instruments are valued using unadjusted quoted prices in active markets and are classified as Level 1. 39 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements Funds Withheld Payable Under Reinsurance Treaties The funds withheld payable under reinsurance treaties includes: • The funds withheld payable that is held at fair value under the fair value option: the fair value is equal to the fair value of the assets held as collateral, which primarily consists of policy loans using industry standard valuation techniques. • The funds withheld embedded derivative: the fair value is determined based upon a total return swap technique referencing the fair value of the investments held under the reinsurance contract and requires certain significant unobservable inputs. Both are considered Level 3 in the fair value hierarchy. Separate Account Assets Separate account assets are comprised of investments in mutual funds that transact regularly, but do not trade in active markets as they are not publicly available and are categorized as Level 2 assets. Market Risk Benefits Our market risk benefits ("MRB") assets and MRB liabilities are reported separately on our Condensed Consolidated Balance Sheets. Increases to an asset or decreases to a liability are described as favorable changes to fair value. Changes in fair value are reported in Market risk benefits (gains) losses, net on the Condensed Consolidated Income Statements. However, the change in fair value related to our own non-performance risk is recognized as a component of other comprehensive income ("OCI") and is reported in Change in non-performance on market risk benefits, net of tax expense (benefit) on the Condensed Consolidated Statements of Comprehensive Income (Loss). Variable Annuities Variable annuity contracts issued by the Company may include various guaranteed minimum death, withdrawal, income and accumulation benefits, which are classified as MRBs and measured at fair value. The fair value of variable annuity guaranteed benefit features classified as MRBs, which have explicit fees, are measured using the attributed fee method as the difference between the present value of projected future liabilities and the present value of projected attributed fees. At the inception of the contract, the Company attributes to the MRB a portion of total fees expected to be assessed against the contract holder's account value to offset the projected claims over the lifetime of the contract. The attributed fee is expressed as a percentage of total projected future fees at inception of the contract. This percentage of total projected fees is considered a fixed term of the MRB feature and is held static over the life of the contract. As the Company may issue contracts that have projected future liabilities greater than the projected future guaranteed benefit fees at issue, the Company may also attribute mortality and expense charges when performing this calculation. The percentage of guaranteed benefit fees and the percentage of mortality and expense charges may not exceed 100% of the total projected fees as of contract inception. In subsequent valuations, both the present value of future projected liabilities and the present value of projected attributed fees are remeasured based on current market conditions and policyholder behavior assumptions. The Company has ceded the guaranteed minimum income benefit (“GMIB”) features elected on certain annuity contracts to an unrelated party. The GMIBs ceded under this reinsurance treaty are classified as a MRB in their entirety. The reinsurance contract is measured at fair value and reported in Reinsurance recoverable on market risk benefits. Changes in fair value are recorded in Market risk benefits (gains) losses, net. Due to the inability to economically reinsure or hedge new issues of the GMIB, the Company discontinued offering the benefit in 2009. Fair values for MRBs related to variable annuities, including the contract reinsuring GMIB features, are calculated using internally developed models because active, observable markets do not exist for those guaranteed benefits. 40 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements The fair value calculation is based on the present value of future cash flows comprised of future expected benefit payments, less future attributed rider fees, over the lives of the contracts. Estimating these cash flows requires numerous estimates and subjective judgments related to capital market inputs, as well as actuarially determined assumptions related to expectations concerning policyholder behavior. Capital market inputs include expected market rates of return, market volatility, correlations of market index returns to fund returns, and discount rates, which include an adjustment for non-performance risk. The more significant actuarial assumptions include benefit utilization by policyholders, lapse, mortality, and withdrawal rates. Best estimate assumptions plus risk margins are used as applicable. At each valuation date, the fair value calculation reflects expected returns based on treasury rates as of that date to determine the value of expected future cash flows produced in a stochastic process. Volatility assumptions are based on available market data for implied market volatility for durations up to 5 years, grading to a historical volatility level by year 10, where such long-term historical volatility levels contain an explicit risk margin. Non-performance risk is incorporated into the calculation through the adjustment of the risk-free rate curve based on credit spreads for debt and debt-like instruments issued by the Company or its insurance operating subsidiaries, adjusted, as necessary, to reflect the financial strength ratings of the issuing insurance subsidiaries. Risk margins are also incorporated into the model assumptions, particularly for policyholder behavior. Estimates of future policyholder behavior are subjective and are based primarily on the Company’s experience. As markets change, mature and evolve and actual policyholder behavior emerges, management evaluates the appropriateness of its assumptions for the fair value model. The use of the models and assumptions described above requires a significant amount of judgment. Management believes this results in an amount that the Company would be required to transfer for a liability, or receive for an asset, to or from a willing buyer or seller, if one existed, for those market participants to assume the risks associated with the guaranteed benefits and the related reinsurance. However, the ultimate settlement amount of the asset or liability, which is currently unknown, could likely be significantly different than this fair value. Fixed Index Annuities and RILA Our FIA and RILA contracts may be issued with features that guarantee benefits that are payable upon death (GMDB) or upon depletion of funds (GMWB). These features are classified as MRBs and measured at fair value. Where the guaranteed benefit features have explicit fees, the fair value of the MRB is measured as the difference between the present value of projected future guaranteed benefits and the present value of projected attributed fees (the attributed fee method). At inception of the contract, the Company attributes a percentage of total projected future fees expected to be assessed against the policyholder to offset the projected future guaranteed benefits over the lifetime of the contract. Where the projected attributed fees are sufficient to offset the projected guaranteed benefits at issue, the MRB has an initial fair value of zero resulting in no gain or loss on issuance of the contract. If the projected attributed fees are insufficient to offset the projected guaranteed benefits at issue, an MRB liability is recognized and the value of the MRB is deducted from the host contract liability resulting in no gain or loss on issuance of the contract. If the guaranteed benefits do not have explicit fees, the fair value of the MRB is measured as the present value of projected future guaranteed benefits. At inception, the initial value of the MRB is deducted from the host contract liability resulting in no gain or loss on issuance of the contract. See Note 12 - Market Risk Benefits of these Notes to Condensed Consolidated Financial Statements for more information regarding MRBs. 41 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements Indexed-Linked Crediting Derivative Feature in Fixed Index Annuities and RILA The fair value of the index-linked crediting derivative feature embedded in fixed index annuities and RILA, included in Annuity Reserves in the above tables, is calculated using the closed form Black-Scholes Option Pricing model or Monte Carlo simulations, as appropriate for the type of option. The calculation incorporates such factors as the volatility of returns, the level of interest rates and the time remaining until the option expires. Additionally, although not a significant input, assumed withdrawal rates are used to estimate the expected volume of embedded options that will be realized by policyholders. Notes Issued by Consolidated VIEs These notes are issued by CLOs and are carried at fair value under the fair value option based on the fair values of corresponding fixed maturity collateral. The CLO liabilities are also reduced by the fair value of the beneficial interest the Company retains in the CLO and the carrying value of any beneficial interests that represent compensation for services. As the notes are valued based on the reference collateral, they are classified as Level 2. Fair Value Option The Company elected the fair value option for: • Debt securities reflected on the Company’s Condensed Consolidated Balance Sheets as debt securities related to: ◦ certain consolidated investments totaling $ 2,650 million and $ 2,698 million at March 31, 2026 and December 31, 2025, respectively. ◦ certain debt securities the Company purchased during the third quarter of 2024, for purposes of mitigating components of exposure to changes in the value of certain market risk benefits. The Company elected the fair value option on these debt securities, with changes in fair value reflected in net income, to align with the corresponding changes in the value of the market risk benefits recognized through net income. These debt securities totaled $ 695 million and $ 766 million at March 31, 2026 and December 31, 2025, respectively. • Certain funds withheld assets, which are held as collateral for reinsurance, totaling $ 3,758 million and $ 3,867 million at March 31, 2026 and December 31, 2025, respectively, as discussed above, and include mortgage loans as discussed below. • Certain mortgage loans held under the funds withheld reinsurance agreement with Athene. The fair value option was elected for these mortgage loans, purchased or funded after December 31, 2021, to mitigate inconsistency in earnings that would otherwise result between these mortgage loan assets and the funds withheld liability, including the associated embedded derivative, and are valued using third-party pricing services. Changes in fair value are reflected in net investment income on the Condensed Consolidated Income Statements. The fair value and aggregate contractual principal for mortgage loans where the fair value option was elected after December 31, 2021, were as follows (in millions): March 31, 2026 December 31, 2025 Fair value $ 196 $ 324 Aggregate contractual principal 212 330 As of March 31, 2026, no loans in good standing for which the fair value option was elected were in non-accrual status, and no loans were more than 90 days past due and still accruing interest. • Notes issued by consolidated VIEs totaling $ 2,543 million and $ 2,578 million at March 31, 2026 and December 31, 2025, respectively. 42 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements Income and changes in unrealized gains and losses on other assets for which the Company has elected the fair value option are immaterial to the Company’s Condensed Consolidated Financial Statements. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following tables summarize the Company’s assets and liabilities that are carried at fair value by hierarchy levels (in millions): March 31, 2026 Total Level 1 Level 2 Level 3 Assets Debt securities U.S. government securities $ 3,125 $ 3,125 $ — $ — Other government securities 1,055 — 1,055 — Public utilities 6,212 — 6,212 — Corporate securities 33,108 — 32,963 145 Residential mortgage-backed 467 — 467 — Commercial mortgage-backed 1,954 — 1,954 — Other asset-backed securities 6,027 — 5,749 278 Equity securities 243 102 132 9 Mortgage loans 196 — — 196 Limited partnerships (1) 276 — — 276 Policy loans 3,556 — — 3,556 Freestanding derivative instruments 701 — 701 — Cash and cash equivalents 5,539 5,539 — — Reinsurance recoverable on market risk benefits 121 — — 121 Market risk benefit assets 6,701 — — 6,701 Separate account assets 223,452 — 223,452 — Total $ 292,733 $ 8,766 $ 272,685 $ 11,282 Liabilities Embedded derivative liabilities (2) $ 6,317 $ — $ 6,317 $ — Funds withheld payable under reinsurance treaties (3) 1,979 — — 1,979 Freestanding derivative instruments 238 — 238 — Notes issued by consolidated VIEs 2,543 — 2,543 — Market risk benefit liabilities 3,971 — — 3,971 Total $ 15,048 $ — $ 9,098 $ 5,950 (1) Excludes $ 2,620 million of limited partnership investments measured at NAV equivalent. (2) Includes the embedded derivative liabilities of $ 5,499 million related to RILA and $ 818 million liability of fixed index annuities, both included in other contract holder funds on the Condensed Consolidated Balance Sheets. (3) Includes the Athene embedded derivative asset of $ 1,765 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. 43 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements December 31, 2025 Total Level 1 Level 2 Level 3 Assets Debt securities U.S. government securities $ 3,005 $ 3,005 $ — $ — Other government securities 1,065 — 1,065 — Public utilities 6,146 — 6,146 — Corporate securities 32,916 — 32,570 346 Residential mortgage-backed 442 — 442 — Commercial mortgage-backed 1,829 — 1,829 — Other asset-backed securities 5,388 — 4,962 426 Equity securities 172 10 155 7 Mortgage loans 324 — — 324 Limited partnerships (1) 250 — — 250 Policy loans 3,537 — — 3,537 Freestanding derivative instruments 448 — 448 — Cash and cash equivalents 5,704 5,704 — — Reinsurance recoverable on market risk benefits 118 — — 118 Market risk benefit assets 7,867 — — 7,867 Separate account assets 236,496 — 236,496 — Total $ 305,707 $ 8,719 $ 284,113 $ 12,875 Liabilities Embedded derivative liabilities (2) $ 6,906 $ — $ 6,906 $ — Funds withheld payable under reinsurance treaties (3) 1,971 — — 1,971 Freestanding derivative instruments 257 — 257 — Notes issued by consolidated VIEs 2,578 — 2,578 — Market risk benefit liabilities 3,754 — — 3,754 Total $ 15,466 $ — $ 9,741 $ 5,725 (1) Excludes $ 2,586 million of limited partnership investments measured at NAV equivalent. (2) Includes the embedded derivative liabilities of $ 6,043 million related to RILA and $ 863 million of fixed index annuities, both included in other contract holder funds on the Condensed Consolidated Balance Sheets. (3) Includes the Athene embedded derivative asset of $ 1,752 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. 44 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) Level 3 Assets and Liabilities by Price Source The table below presents the balances of Level 3 assets and liabilities measured at fair value with their corresponding pricing sources (in millions): March 31, 2026 Assets Total Internal External Debt securities: Corporate $ 145 $ 29 $ 116 Other asset-backed securities 278 83 195 Equity securities 9 1 8 Mortgage loans 196 — 196 Limited partnerships 276 1 275 Policy loans 3,556 3,556 — Reinsurance recoverable on market risk benefits 121 121 — Market risk benefit assets 6,701 6,701 — Total $ 11,282 $ 10,492 $ 790 Liabilities Funds withheld payable under reinsurance treaties (1) 1,979 1,979 — Market risk benefit liabilities 3,971 3,971 — Total $ 5,950 $ 5,950 $ — (1) Includes the Athene Embedded Derivative asset of $ 1,765 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. December 31, 2025 Assets Total Internal External Debt securities: Corporate $ 346 $ 31 $ 315 Other asset-backed securities 426 84 342 Equity securities 7 1 6 Mortgage loans 324 — 324 Limited partnerships 250 1 249 Policy loans 3,537 3,537 — Reinsurance recoverable on market risk benefits 118 118 — Market risk benefit assets 7,867 7,867 — Total $ 12,875 $ 11,639 $ 1,236 Liabilities Funds withheld payable under reinsurance treaties (1) 1,971 1,971 — Market risk benefit liabilities 3,754 3,754 — Total $ 5,725 $ 5,725 $ — (1) Includes the Athene Embedded Derivative asset of $ 1,752 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. External pricing sources for securities represent unadjusted prices from independent pricing services and independent indicative broker quotes where pricing inputs are not readily available. 45 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements Quantitative Information Regarding Internally-Priced Level 3 Assets and Liabilities The table below presents quantitative information on internally-priced Level 3 assets and liabilities that use significant unobservable inputs (dollar amounts in millions): As of March 31, 2026 Fair Value Valuation Technique(s) Significant Unobservable Input(s) Assumption or Input Range Impact of Increase in Input on Fair Value Assets Reinsurance recoverable on market risk benefits $ 121 Discounted cash flow Mortality (1) 0.01 % - 23.31 % Increase Lapse (2) 1.51 % - 13.43 % Increase Utilization (3) 0.00 % - 50.00 % Decrease Withdrawal (4) 41.00 % - 48.50 % Decrease Non-performance risk adjustment (5) 0.38 % - 1.22 % Increase Long-term Equity Volatility (6) 17.50 % - 23.50 % Decrease Market risk benefit assets $ 6,701 Discounted cash flow Mortality (1) 0.00 % - 28.14 % Increase Lapse (2) 0.05 % - 51.00 % Increase Utilization (3) 0.00 % - 100.00 % Decrease Withdrawal (4) 4.15 % - 100.00 % Decrease Non-performance risk adjustment (5) 0.92 % - 1.98 % Increase Long-term Equity Volatility (6) 17.50 % - 23.50 % Decrease Liabilities Market risk benefit liabilities $ 3,971 Discounted cash flow Mortality (1) 0.00 % - 28.14 % Decrease Lapse (2) 0.05 % - 51.00 % Decrease Utilization (3) 0.00 % - 100.00 % Increase Withdrawal (4) 4.15 % - 100.00 % Increase Non-performance risk adjustment (5) 0.92 % - 1.98 % Decrease Long-term Equity Volatility (6) 17.50 % - 23.50 % Increase (1) Mortality rates vary by attained age, guaranteed benefit election, and duration. The range displayed reflects ages from the minimum issue age for the benefit through age 95, which corresponds to the typical maturity age. A mortality improvement assumption is also applied. (2) Base lapse rates vary by contract-level factors, such as product type, surrender charge schedule and guaranteed benefits election. Lapse rates are further adjusted based on the degree to which a guaranteed benefit is in-the-money, with lower lapse rates applying when benefits are more in-the-money. Lapse rates are also adjusted to reflect lower lapse expectations when guaranteed benefits are utilized. (3) The utilization rate represents the expected percentage of contracts that will utilize the benefit through annuitization (GMIB) or commencement of withdrawals (GMWB). Utilization may vary by benefit type, attained age, duration, tax qualification status, benefit provision, and degree to which the guaranteed benefit is in-the-money. (4) The withdrawal rate represents the percentage of annual withdrawal assumed relative to the maximum allowable withdrawal amount under the free partial withdrawal provision or the GMWB, as applicable. Free partial withdrawal rates vary based on the product type, duration, and GMAB election. Withdrawal rates on contracts with a GMWB vary based on attained age, tax qualification status, GMWB type and GMWB benefit provisions. (5) Non-performance risk adjustment is applied as a spread over the risk-free rate to determine the rate used to discount the related cash flows and varies by projection year. (6) Long-term equity volatility represents the equity volatility beyond the period for which observable equity volatilities are available. 46 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements As of December 31, 2025 Fair Value Valuation Technique(s) Significant Unobservable Input(s) Assumption or Input Range Impact of Increase in Input on Fair Value Assets Reinsurance recoverable on market risk benefits $ 118 Discounted cash flow Mortality (1) 0.01 % - 23.31 % Increase Lapse (2) 1.51 % - 13.43 % Increase Utilization (3) 0.00 % - 50.00 % Decrease Withdrawal (4) 41.00 % - 48.50 % Decrease Non-performance risk adjustment (5) 0.30 % - 1.09 % Increase Long-term Equity Volatility (6) 17.50 % 23.50 % Decrease Market risk benefit assets $ 7,867 Discounted cash flow Mortality (1) 0.00 % - 28.14 % Increase Lapse (2) 0.05 % - 51.00 % Increase Utilization (3) 0.00 % - 100.00 % Decrease Withdrawal (4) 4.15 % - 100.00 % Decrease Non-performance risk adjustment (5) 0.57 % - 1.67 % Increase Long-term Equity Volatility (6) 17.50 % 23.50 % Decrease Liabilities Market risk benefit liabilities $ 3,754 Discounted cash flow Mortality (1) 0.00 % - 28.14 % Decrease Lapse (2) 0.05 % - 51.00 % Decrease Utilization (3) 0.00 % - 100.00 % Increase Withdrawal (4) 4.15 % - 100.00 % Increase Non-performance risk adjustment (5) 0.57 % - 1.67 % Decrease Long-term Equity Volatility (6) 17.50 % 23.50 % Increase (1) Mortality rates vary by attained age, guaranteed benefit election, and duration. The range displayed reflects ages from the minimum issue age for the benefit through age 95, which corresponds to the typical maturity age. A mortality improvement assumption is also applied. (2) Base lapse rates vary by contract-level factors, such as product type, surrender charge schedule and guaranteed benefits election. Lapse rates are further adjusted based on the degree to which a guaranteed benefit is in-the-money, with lower lapse rates applying when benefits are more in-the-money. Lapse rates are also adjusted to reflect lower lapse expectations when guaranteed benefits are utilized. (3) The utilization rate represents the expected percentage of contracts that will utilize the benefit through annuitization (GMIB) or commencement of withdrawals (GMWB). Utilization may vary by benefit type, attained age, duration, tax qualification status, benefit provision, and degree to which the guaranteed benefit is in-the-money. (4) The withdrawal rate represents the percentage of annual withdrawal assumed relative to the maximum allowable withdrawal amount under the free partial withdrawal provision or the GMWB, as applicable. Free partial withdrawal rates vary based on the product type, duration, and GMAB election. Withdrawal rates on contracts with a GMWB vary based on attained age, tax qualification status, GMWB type and GMWB benefit provisions. (5) Non-performance risk adjustment is applied as a spread over the risk-free rate to determine the rate used to discount the related cash flows and varies by projection year. (6) Long-term equity volatility represents the equity volatility beyond the period for which observable equity volatilities are available. 47 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements Sensitivity to Changes in Unobservable Inputs The following is a general description of sensitivities of significant unobservable inputs and their impact on the fair value measurement for the assets and liabilities reflected in the tables above. • Investments: At March 31, 2026 and December 31, 2025, $ 114 million and $ 117 million, respectively, of debt securities, equity securities, and limited partnerships are fair valued using techniques incorporating unobservable inputs and are classified in Level 3 of the fair value hierarchy. For these assets, their unobservable inputs and ranges of possible inputs do not materially affect their fair valuations and have been excluded from the quantitative information in the tables above. • Policy Loans: Policy loans that support funds withheld reinsurance agreements that are held at fair value under the fair value option on the Company’s Condensed Consolidated Balance Sheets are excluded from the tables above. These policy loans do not have a stated maturity and the balances, plus accrued investment income, are repaid either by the policyholder or with proceeds from the policy. Due to the collateralized nature of policy loans and unpredictable timing of payments, the Company believes the carrying value of policy loans, which includes accrued investment income, approximates fair value and is classified as Level 3 within the fair value hierarchy. • Funds Withheld Payable: ◦ Under the Reassure America Life Insurance Company reinsurance treaties, fair value is determined based upon the fair value of the funds withheld investments held by the Company and is excluded from the tables above. ◦ Under the Athene reinsurance treaty, the calculation includes the Athene embedded derivative that is measured at fair value. The valuation of the embedded derivative utilizes a total return swap technique that incorporates the fair value of the invested assets supporting the reinsurance agreement as a component of the valuation and is excluded from the tables above. As a result, these valuations require certain significant inputs that are generally not observable and, accordingly, the valuation is considered Level 3 in the fair value hierarchy. • GMIB reinsurance recoverable: fair value calculation is based on the present value of future cash flows comprised of future expected reinsurance benefit receipts, less future attributed premium payments to reinsurers, over the lives of the contracts. Estimating these cash flows requires actuarially determined assumptions related to expectations concerning policyholder behavior and long-term market volatility. The more significant policyholder behavior actuarial assumptions include benefit utilization, lapse, and mortality. • MRB asset and liability: fair value calculation is based on the present value of future cash flows comprised of future expected benefit payments, less future attributed fees (if applicable), over the lives of the contracts. Estimating these cash flows requires numerous estimates and subjective judgments related to capital market inputs, as well as actuarially determined assumptions related to expectations concerning policyholder behavior. The more significant actuarial assumptions include benefit utilization by policyholders, lapse, mortality, and withdrawal rates. Best estimate assumptions plus risk margins are used as applicable. The tables below provide roll-forwards for the three months ended March 31, 2026 and 2025 of the financial instruments for which significant unobservable inputs (Level 3) are used in the fair value measurement. Gains and losses in the tables below include changes in fair value due partly to observable and unobservable factors. The Company utilizes derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instruments hedging the related risks may not be classified within the same fair value hierarchy level as the associated assets and liabilities. Therefore, the impact of the derivative instruments reported in Level 3 may vary significantly from the total income effect of the hedged instruments. 48 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of January 1, Income Comprehensive and (out of) March 31, Three Months Ended March 31, 2026 2026 (Loss) Income (Loss) Settlements Level 3 2026 Assets Debt securities Corporate securities $ 346 $ 2 $ 2 $ ( 190 ) $ ( 15 ) $ 145 Other asset-backed securities 426 ( 19 ) ( 1 ) ( 59 ) ( 69 ) 278 Equity securities 7 2 — — — 9 Mortgage loans 324 2 — ( 130 ) — 196 Limited partnerships 250 4 — 12 10 276 Policy loans 3,537 ( 12 ) — 31 — 3,556 Reinsurance recoverable on market risk benefits 118 3 — — — 121 Market risk benefit assets 7,867 ( 1,166 ) — — — 6,701 Liabilities Funds withheld payable under reinsurance treaties ( 1,971 ) 24 — ( 32 ) — ( 1,979 ) Market risk benefit liabilities ( 3,754 ) ( 507 ) 333 ( 43 ) — ( 3,971 ) Total Realized/Unrealized Gains (Losses) Included in Purchases, Fair Value Sales, Transfers Fair Value as of Net Other Issuances in and/or as of January 1, Income Comprehensive and (out of) March 31, Three Months Ended March 31, 2025 2025 (Loss) Income (Loss) Settlements Level 3 2025 Assets Debt securities Public utilities $ 44 $ — $ — $ ( 44 ) $ — $ — Corporate securities 274 — 4 27 ( 5 ) 300 Other asset-backed securities 661 — ( 2 ) 11 121 791 Equity securities 7 — — — — 7 Mortgage loans 449 4 — ( 2 ) — 451 Limited partnerships 195 7 — 1 — 203 Policy loans 3,489 ( 10 ) — 13 — 3,492 Reinsurance recoverable on market risk benefits 121 5 — — — 126 Market risk benefit assets 8,899 ( 1,573 ) — — — 7,326 Liabilities Funds withheld payable under reinsurance treaties ( 1,353 ) ( 193 ) — ( 14 ) — ( 1,560 ) Market risk benefit liabilities ( 3,774 ) ( 678 ) 327 — — ( 4,125 ) 49 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements The components of the amounts included in purchases, sales, issuances and settlements for the three months ended March 31, 2026 and 2025 shown above are as follows (in millions): Three Months Ended March 31, 2026 Purchases Sales Issuances Settlements Total Assets Debt securities Corporate securities $ 1 $ ( 191 ) $ — $ — $ ( 190 ) Other asset-backed securities 57 ( 116 ) — — ( 59 ) Mortgage loans 20 ( 150 ) — — ( 130 ) Limited partnerships 13 ( 1 ) — — 12 Policy loans — — 78 ( 47 ) 31 Total $ 91 $ ( 458 ) $ 78 $ ( 47 ) $ ( 336 ) Liabilities Funds withheld payable under reinsurance treaties $ — $ — $ ( 184 ) $ 152 $ ( 32 ) Market risk benefit liabilities — — ( 43 ) — ( 43 ) Total $ — $ — $ ( 227 ) $ 152 $ ( 75 ) Three Months Ended March 31, 2025 Purchases Sales Issuances Settlements Total Assets Debt securities Public utilities $ — $ ( 44 ) $ — $ — $ ( 44 ) Corporate securities 104 ( 77 ) — — 27 Other asset-backed securities 158 ( 147 ) — — 11 Mortgage loans 81 ( 83 ) — — ( 2 ) Limited partnerships 1 — — — 1 Policy loans — — 61 ( 48 ) 13 Total $ 344 $ ( 351 ) $ 61 $ ( 48 ) $ 6 Liabilities Funds withheld payable under reinsurance treaties $ — $ — $ ( 116 ) $ 102 $ ( 14 ) For the three months ended March 31, 2026, transfers from Level 3 to Level 2 of the fair value hierarchy were $ 91 million, transfers from Level 2 to Level 3 were $ 17 million, and transfers from Level 3 to NAV equivalent were nil . For the three months ended March 31, 2025, transfers from Level 3 to Level 2 of the fair value hierarchy were $ 58 million, transfers from Level 2 to Level 3 were $ 174 million, and transfers from Level 3 to NAV equivalent were nil . 50 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements The portion of gains (losses) included in net income (loss) or OCI attributable to the change in unrealized gains and losses on Level 3 financial instruments still held was as follows (in millions): Three Months Ended March 31, 2026 2025 Included in Net Income Included in OCI Included in Net Income Included in OCI Assets Debt securities Corporate securities $ 2 $ ( 4 ) $ — $ 4 Other asset-backed securities ( 20 ) ( 1 ) — ( 3 ) Equity securities 2 — — — Mortgage loans 2 — 4 — Limited partnerships 4 — 7 — Policy loans ( 12 ) — ( 10 ) — Reinsurance recoverable on market risk benefits 3 — 5 — Market risk benefit assets ( 1,166 ) — ( 1,573 ) — Liabilities Funds withheld payable under reinsurance treaties 24 — ( 193 ) — Market risk benefit liabilities ( 507 ) 333 ( 678 ) 327 Fair Value of Financial Instruments Carried at Other Than Fair Value The table below presents the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value (in millions): March 31, 2026 Fair Value Carrying Value Total Level 1 Level 2 Level 3 Assets Mortgage loans $ 10,248 $ 9,992 $ — $ — $ 9,992 Policy loans 875 875 — — 875 FHLBI capital stock 119 119 119 — — Liabilities Annuity reserves (1) $ 40,683 $ 38,366 $ — $ — $ 38,366 Guaranteed investment contracts and funding agreements (2) 11,141 10,933 — — 10,933 Funds withheld payable under reinsurance treaties 12,532 12,532 — — 12,532 Long-term debt 2,027 1,831 — 1,831 — Securities lending payable (3) 54 54 — 54 — Repurchase agreements (3) 451 451 — 451 — Separate account liabilities (5) 223,452 223,452 — 223,452 — 51 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements December 31, 2025 Fair Value Carrying Value Total Level 1 Level 2 Level 3 Assets Mortgage loans $ 9,887 $ 9,624 $ — $ — $ 9,624 Policy loans 889 889 — — 889 FHLBI capital stock 119 119 119 — — Liabilities Annuity reserves (1) $ 39,059 $ 38,552 $ — $ — $ 38,552 Guaranteed investment contracts and funding agreements (2) 11,021 11,077 — — 11,077 Funds withheld payable under reinsurance treaties 12,989 12,989 — — 12,989 Long-term debt 2,030 1,877 — 1,877 — Securities lending payable (3) 35 35 — 35 — Repurchase agreements (3) 1,001 1,001 — 1,001 — Separate account liabilities (5) 236,496 236,496 — 236,496 — (1) Annuity reserves represent only the components of other contract holder funds that are considered to be financial instruments. (2) Included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets. (3) Included as a component of repurchase agreements and securities lending payable on the Condensed Consolidated Balance Sheets. (4) Included as a component of other liabilities on the Condensed Consolidated Balance Sheets. (5) The values of separate account liabilities are set equal to the values of separate account assets. The following is a discussion of the methodologies used to determine fair values of the financial instruments that are not reported at fair value as shown in the table above: • Mortgage Loans: Fair values are generally determined by discounting expected future cash flows at current market interest rates, inclusive of a credit spread, for similar quality loans. For loans whose value is dependent on the underlying property, fair value is the estimated value of the collateral. Certain characteristics considered significant in determining the spread or collateral value may be based on internally developed estimates. As a result, these investments have been classified as Level 3 within the fair value hierarchy. Mortgage loans held under a funds withheld reinsurance agreement are valued using third-party pricing services, which may use economic inputs, geographical information, and property specific assumptions in deriving the fair value price. The Company reviews the valuations from these pricing providers to ensure they are reasonable. Due to lack of observable inputs, these investments have been classified as Level 3 within the fair value hierarchy. • Policy Loans: As described under “Policy Loans” in Note 4 – Investments of these Notes to Condensed Consolidated Financial Statements, due to the collateralized nature of policy loans and unpredictable timing of payments, the Company believes the carrying value of policy loans approximates fair value. The non-reinsurance related component of policy loans has been classified as Level 3 within the fair value hierarchy. • FHLBI Capital Stock: FHLBI capital stock, which is included in other invested assets, can only be sold to FHLBI at a constant price of $ 100 per share. Due to the lack of valuation uncertainty, the investment has been classified as Level 1. • Other Contract Holder Funds: Fair values for immediate annuities without mortality features are derived by discounting the future estimated cash flows using current market interest rates for similar maturities. Fair values for deferred annuities, including the fixed option on variable annuities, fixed annuities, fixed index annuities and RILAs, are determined using projected future cash flows discounted at current market interest rates. Fair values for guaranteed investment contracts and funding agreements are based on the present value of future cash flows discounted at current market interest rates. 52 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements • Funds Withheld Payable Under Reinsurance Treaties: The fair value of the funds withheld payable is equal to the fair value of the assets held as collateral, which primarily consists of bonds, mortgages, limited partnerships, and cash and cash equivalents. The fair value of the assets generally uses industry standard valuation techniques as described above and the funds withheld payable components are valued consistent with the assets in the fair value hierarchy and the funds withheld payable is classified in its entirety according to the lowest level input that is significant to the determination of the fair value. The funds withheld payable is classified as Level 3 within the fair value hierarchy. • Debt: Fair values for the Company’s surplus notes and long-term debt are generally determined by prices obtained from independent broker dealers or discounted cash flow models. Such prices are derived from market observable inputs and are classified as Level 2. • Securities Lending Payable: The Company’s securities lending payable is set equal to the cash collateral received. Due to the short-term nature of the loans, carrying value is a reasonable estimate of fair value and is classified as Level 2. • FHLB Advances: Carrying value of the Company’s FHLB advances, which are included in other liabilities, is considered a reasonable estimate of fair value due to their short-term maturities and are classified as Level 2. • Repurchase Agreements: Carrying value of the Company’s repurchase agreements is considered a reasonable estimate of fair value due to their short-term maturities and are classified as Level 2. • Separate Account Liabilities: The values of separate account liabilities are set equal to the values of separate account assets, which are comprised of investments in mutual funds that transact regularly, but do not trade in active markets as they are not publicly available and are categorized as Level 2. 7. Deferred Acquisition Costs Certain costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as deferred acquisition costs ("DAC") in the period in which they are incurred. These costs primarily pertain to commissions and certain costs associated with policy issuance and underwriting. All other acquisition costs are expensed as incurred. Contracts are grouped into cohorts by contract type and issue year. For traditional and limited-payment insurance contracts, contracts are grouped consistent with the groupings used in estimating the associated liability. DAC are amortized into expense on a constant level basis over the expected term of the grouped contracts. For traditional and limited-payment insurance contracts, amortization is determined based on projected in force amounts. For non-traditional contracts, amortization is determined based on projected policy counts . The expected term used to amortize DAC is determined using best estimate assumptions, including mortality and persistency, consistent with the best estimate assumptions used to determine the reserve for future policy benefits, MRBs, and additional liabilities for applicable contracts. For amortization of DAC related to contracts without these balances, assumptions used to determine expected term are developed in a similar manner. The amortization rate is determined using all information available as of the end of the reporting period, including actual experience and any assumption updates. Annually, or as circumstances warrant, a comprehensive review of assumptions is conducted, and assumptions are revised as appropriate. If assumptions are revised, the amortization rate is calculated using revised assumptions such that the effect of revised assumptions is recognized prospectively as of the beginning of that reporting period. Unamortized DAC are written off when a contract is internally replaced and substantially changed. Substantially unchanged contracts are treated as a continuation of the replaced contract, with no change to the unamortized DAC at the time of the replacement. 53 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 7. Deferred Acquisition Costs The following table presents the roll-forward of the DAC (in millions). The current period amortization is based on the end of the period estimates of mortality and persistency. The amortization pattern is revised on a prospective basis at the beginning of the period based on the period’s actual experience. Three Months Ended March 31, Year Ended December 31, 2026 2025 Variable Annuities Balance, beginning of period $ 10,810 $ 11,314 Deferrals of acquisition costs 141 526 Amortization ( 255 ) ( 1,030 ) Variable Annuities balance, end of period $ 10,696 $ 10,810 RILA Balance, beginning of period $ 637 $ 399 Deferrals of acquisition costs 82 294 Amortization ( 20 ) ( 56 ) RILA balance, end of period $ 699 $ 637 Reconciliation of total DAC Variable Annuities balance, end of period $ 10,696 $ 10,810 RILA balance, end of period 699 637 Other product lines, end of period 239 213 Total balance, end of period $ 11,634 $ 11,660 8. Reinsurance The Company, through its subsidiary insurance companies, assumes and cedes reinsurance from and to other insurance companies as a means of managing capital and risk exposures. However, if the reinsurer is unable to meet its obligations, the originating issuer of the coverage retains the liability. The Company reinsures certain of its risks to other reinsurers on a coinsurance, coinsurance with funds withheld, modified coinsurance, or yearly renewable term basis. The Company regularly monitors the financial strength ratings of its reinsurers. Athene Reinsurance The Company entered into a funds withheld coinsurance agreement with Athene effective June 1, 2020, to reinsure on a 100 % quota share basis, a block of Jackson’s in-force fixed and fixed-index annuity product liabilities in exchange for a $ 1.2 billion ceding commission. The coinsurance with funds withheld agreement ("the coinsurance agreement") required Jackson to establish a segregated account in which the investments supporting the ceded obligations are maintained. While the economic benefits of the investments flow to Athene, Jackson retains physical possession and legal ownership of the investments supporting the reserve. Further, the investments in the segregated account are not available to settle any policyholder obligations other than those specifically covered by the coinsurance agreement and are not available to settle obligations to general creditors of Jackson. The profit and loss with respect to obligations ceded to Athene are included in periodic net settlements pursuant to the coinsurance agreement. To further support its obligations under the coinsurance agreement, Athene procured $ 1.1 billion in letters of credit for Jackson’s benefit and established a trust account for Jackson’s benefit, which had a book value of approximately $ 57 million at March 31, 2026. Swiss Re Reinsurance Jackson has three retrocession reinsurance agreements (“retro treaties”) with Swiss Reinsurance Company Ltd. (“SRZ”). Pursuant to these retro treaties, Jackson ceded certain blocks of business to SRZ on a 100 % coinsurance with funds withheld basis, subject to pre-existing reinsurance with other parties. As a result of the reinsurance agreements with SRZ, Jackson withholds certain assets, primarily in the form of policy loans and debt securities, as collateral for the reinsurance recoverable. 54 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 8. Reinsurance The Company has also acquired certain blocks of business that are closed to new business and wholly ceded to non-affiliates. These include both direct and assumed accident and health businesses, direct and assumed life insurance business, and certain institutional annuities. GMIB Reinsurance The Company’s guaranteed minimum income benefits (“GMIBs”) are reinsured with an unrelated party. GMIB reinsured benefits are subject to aggregate annual claim limits. Deductibles also apply on reinsurance of GMIB business issued since March 1, 2005. The Company discontinued offering the GMIB in 2009. Reinsurance Recoverables and Reinsured Market Risk Benefits Ceded reinsurance agreements are reported on a gross basis on the Company’s Condensed Consolidated Balance Sheets as an asset for amounts recoverable from reinsurers or as a component of other assets or liabilities for amounts, such as premiums, owed to or due from reinsurers. Reinsurance recoverables relating to reinsurance of traditional and limited-payment contracts are required to be recognized and measured in a manner consistent with liabilities relating to the underlying reinsured contracts, including using consistent assumptions. Reinsurance contracts may be executed subsequent to the direct contract issue dates, and market interest rates may have changed between the date that the underlying insurance contracts were issued and the date the reinsurance contract is recognized in the financial statements, resulting in the underlying discount rate differing between the direct and reinsured business. The Company regularly monitors the financial strength ratings of its reinsurers. At both March 31, 2026 and December 31, 2025, the Company had an allowance for credit losses (“ACL”) of $ 30 million, respectively, on its reinsurance recoverables, which are reported net of ACL on the Condensed Consolidated Balance Sheets. The ACL considers the credit quality of the reinsurer and is generally determined based on probability of default and loss given default assumptions, after considering any applicable collateral arrangements. For reinsurance recoverables that are collateralized, the amount of collateral is expected to be adjusted as necessary as a result of fair value changes in that collateral. If the fair value of the collateral at the reporting date is less than the carrying value of the reinsurance recoverable, the Company recognizes an ACL on the difference between the fair value of the collateral at the reporting date and the carrying value of the reinsurance recoverable. Additions to or releases of the ACL are reported in Death, other policyholder benefits, and changes in reserves, net of deferrals in the Condensed Consolidated Income Statements. Reinsurance recoverable on market risk benefits is recognized at fair value with changes being recognized in current period earnings within market risk benefit (gains) losses, net. Non-performance risk of the reinsurer is incorporated into the calculation through the adjustment of the risk-free rate curve based on credit spreads observed on instruments issued by similarly-rated life insurance companies. The Company’s reinsurance contract that cedes only the GMIB elected on certain variable annuity products is classified as a reinsurance recoverable on market risk benefits. These reinsured MRBs may have direct MRB balances recorded as either assets or liabilities; however, because the unit of account for the reinsured MRB is the reinsurance contract, the ceded MRB is presented in total within reinsurance recoverable on market risk benefits. The fees used to determine the fair value of the reinsurance recoverable on market risk benefits are those defined in the reinsurance contract. Guaranteed benefits related to the optional lifetime income rider offered on certain fixed index annuities are MRBs that are reinsured with Athene. The reinsured MRBs are measured using a non-option valuation approach that uses cash flow assumptions and an attributed fee ratio consistent with those used to measure the MRBs on the direct contract and a discount rate that considers the reinsurer’s credit risk. The attributed fee is locked-in at inception of the contract. 55 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 8. Reinsurance Components of the Company’s reinsurance recoverable excluding MRBs were as follows (in millions): March 31, December 31, 2026 2025 Reserves: Life $ 5,107 $ 5,164 Accident and health 495 525 Annuity benefits (1) 12,699 13,196 Claims liability and other 625 633 Total $ 18,926 $ 19,518 (1) Other annuity benefits primarily attributable to fixed and fixed index annuities reinsured with Athene. Components of the Company’s reinsurance recoverable on market risk benefits were as follows (in millions): March 31, December 31, 2026 2025 Variable annuity $ 43 $ 41 Other product lines 78 77 Total $ 121 $ 118 Reinsurance and Funds Withheld Payable Under Reinsurance Treaties Under the reinsurance agreement with Athene and the retro treaties with SRZ, the Company maintains ownership of the underlying investments instead of transferring them to the reinsurer and, as a result, records a funds withheld liability payable to the reinsurer. Investment returns earned on withheld assets are paid by the Company to the reinsurer, pursuant to the terms of the agreements. Investment income and net gains (losses) on derivatives and investments are reported net of gains or losses on the funds withheld payable under reinsurance treaties. The amounts credited to reinsurers on the funds withheld payable is based on the return earned on those assets. The return earned on the assets is subject to the credit risk of the original issuer of the instrument rather than Jackson’s own creditworthiness, which results in an embedded derivative (total return swap). Funds withheld under reinsurance agreement with Athene The Company recognizes a liability for the embedded derivative related to the funds withheld under the Athene reinsurance agreement within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. The embedded derivative is measured at fair value with changes in fair value reported in net gains (losses) on derivatives and investments in the Condensed Consolidated Income Statements. At inception of the reinsurance agreement with Athene, the fair value of the withheld investments differed from their book value and, accordingly, while the investments are held, the amortization of this difference is reported in net gains (losses) on derivatives and investments in the Condensed Consolidated Income Statements. See Note 5 - Derivative Instruments of these Notes to Condensed Consolidated Financial Statements for more information on the embedded derivative. Funds withheld under reinsurance agreements with SRZ At execution of the retro treaties with SRZ, the Company elected the fair value option for the withheld assets, as well as the related funds withheld payable. Accordingly, the embedded derivative is not bifurcated or separately measured. The funds withheld payable is measured at fair value with changes in fair value reported in net gains (losses) on derivatives and investments. The fair value of the funds withheld payable is equal to the fair value of the assets held as collateral. 56 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 8. Reinsurance The following assets and liabilities were held in support of reserves associated with the Company’s funds withheld reinsurance agreements and were reported in the respective financial statement line items on the Condensed Consolidated Balance Sheets (in millions): March 31, December 31, 2026 2025 Assets Debt securities, available-for-sale $ 7,476 $ 7,947 Debt securities, at fair value under the fair value option 6 6 Equity securities 69 88 Mortgage loans 2,022 2,102 Mortgage loans, at fair value under the fair value option 196 324 Policy loans 3,567 3,548 Freestanding derivative instruments, net 7 ( 4 ) Other invested assets 674 712 Cash and cash equivalents 626 375 Accrued investment income 87 92 Other assets and liabilities, net ( 8 ) 5 Total assets (1) $ 14,722 $ 15,195 Liabilities Funds held under reinsurance treaties (2) $ 14,511 $ 14,960 Total liabilities $ 14,511 $ 14,960 (1) Certain assets are reported at amortized cost while the fair value of those assets is reported in the embedded derivative in the funds withheld liability. (2) Includes funds withheld embedded derivative asset (liability) of $ 1,765 million and $ 1,752 million at March 31, 2026 and December 31, 2025, respectively. The sources of income related to funds withheld under reinsurance treaties reported in net investment income in the Condensed Consolidated Income Statements were as follows (in millions): Three Months Ended March 31, 2026 2025 Debt securities (1) $ 87 $ 100 Equity securities ( 1 ) — Mortgage loans (2) 26 43 Policy loans 87 83 Limited partnerships 8 10 Other investment income 3 4 Total investment income on funds withheld assets 210 240 Other investment expenses on funds withheld assets (3) ( 11 ) ( 13 ) Total net investment income on funds withheld reinsurance treaties $ 199 $ 227 (1) Includes nil and $ 1 million for the three months ended March 31, 2026 and 2025, respectively, related to the change in fair value for securities carried under the fair value option. (2) Includes $ 2 million and $ 4 million for the three months ended March 31, 2026 and 2025, respectively, related to the change in fair value for mortgage loans carried under the fair value option. (3) Includes management fees. 57 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 8. Reinsurance The gains and losses on funds withheld reinsurance treaties as a component of net gains (losses) on derivatives and investments in the Condensed Consolidated Income Statements were as follows (in millions): Three Months Ended March 31, 2026 2025 Available-for-sale securities Realized gains on sale $ 2 $ 5 Realized losses on sale ( 12 ) ( 49 ) Credit loss expense ( 16 ) ( 2 ) Credit loss expense on mortgage loans ( 5 ) ( 4 ) Other 8 7 Net gains (losses) on non-derivative investments ( 23 ) ( 43 ) Net gains (losses) on derivative instruments 4 ( 17 ) Net gains (losses) on funds withheld payable under reinsurance treaties (1) ( 140 ) ( 328 ) Total net gains (losses) on derivatives and investments $ ( 159 ) $ ( 388 ) (1) Includes the Athene embedded derivative gain (loss) of $ 14 million and $( 201 ) million for the three months ended March 31, 2026 and 2025, respectively. 9. Reserves for Future Policy Benefits and Claims Payable Reserves for Future Policy Benefits For non-participating traditional and limited-payment insurance contracts, the reserve for future policy benefits represents the present value of estimated future policy benefits to be paid to or on behalf of policyholders in future periods and certain related expenses less the present value of estimated future net premiums. Reserves for future policy benefits for non-participating traditional and limited-payment insurance contracts are measured using the net premium ratio ("NPR") measurement model. The NPR measurement model accrues for future policy benefits in proportion to the premium revenue recognized. The reserve for future policy benefits is derived from the Company's best estimate of future net premium and future benefits and expenses, which is based on best estimate assumptions including mortality, persistency, claims expense, and discount rate. On an annual basis, or as circumstances warrant, we conduct a comprehensive review of our current best estimate assumptions based on our experience, industry benchmarking, and other factors, as applicable. Expense assumptions are updated based on estimates of expected non-level costs, such as termination or settlement costs, and costs after the premium-paying period and exclude acquisition costs or any costs that are required to be charged to expenses as incurred. Updates to assumptions are applied on a retrospective basis, and the change in the reserve for future policy benefits resulting from updates to assumptions is reported separately in the Condensed Consolidated Income Statements within the (gain) loss from updating future policy benefits cash flow assumptions, net. Each reporting period the reserve for future policy benefits is updated to reflect actual experience to date. The Company establishes cohorts, which are groupings used to measure reserves for future policy benefits. In determining cohorts, the Company considers both qualitative and quantitative factors, including the issue year, type of product, product features, and legal entity. The discount rate used to estimate reserves for future policy benefits is consistent with an upper-medium grade (low-credit risk) fixed-income corporate instrument yield, which has been interpreted to represent a single-A corporate instrument yield. This discount rate curve is determined by fitting a parametric function to yields to maturity and related times to maturity of market observable single-A rated corporate instruments. The discount rate used to recognize interest accretion on the reserves for future policy benefits is locked at the initial measurement of the cohort. Each reporting period thereafter, the reserve for future policy benefits is remeasured using the current discount rate. The difference between the reserve calculated using the current discount rate and the reserve calculated using the locked-in discount rate is recorded in OCI. 58 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 9. Reserves for Future Policy Benefits and Claims Payable For limited-payment insurance contracts, premiums are paid over a period shorter than the period over which benefits are provided. Gross premiums received in excess of the net premium are deferred and recognized as a deferred profit liability ("DPL"). The DPL is included within the reserve for future policy benefits and profits are recognized in income as a component of benefit expenses on a constant relationship with the amount of expected future benefit payments. Interest is accreted on the balance of the DPL using the discount rate locked in at the initial measurement of the cohort. Measurement of the DPL uses best estimate assumptions for mortality. These assumptions are similarly subject to the annual review process discussed above. Additional Liabilities – Universal Life-type For universal life-type insurance contracts, a liability is recognized for the policyholder’s account value as discussed further in Note 10 - Other Contract Holder Funds of these Notes to Condensed Consolidated Financial Statements . Where these contracts provide additional benefits beyond the account balance or base insurance coverage that are not market risk benefits or embedded derivatives, liabilities in addition to the policyholder’s account value are recognized. These additional liabilities for annuitization, death and other insurance benefits are reported within reserves for future policy benefits and claims payable. The methodology uses a benefit ratio defined as a constant percentage of the assessment base. This ratio is multiplied by current period assessments to determine the reserve accrual for the period. The assumptions used in the measurement of the additional liabilities for annuitization, death and other insurance benefits are based on best estimate assumptions including mortality, persistency, investment returns, and discount rates. These assumptions are similarly subject to the annual review process discussed above. As available-for-sale debt securities are carried at fair value, an adjustment is made to these additional liabilities equal to the change in liability that would have occurred if such securities had been sold at their stated fair value and the proceeds reinvested at current yields. This adjustment, along with the change in net unrealized gains (losses) on available-for-sale debt securities, net of applicable tax, is credited or charged directly to equity as a component of OCI. See Note 10 - Other Contract Holder Funds of these Notes to Condensed Consolidated Financial Statements for more information regarding other contract holder funds. Other Future Policy Benefits and Claims Payable In conjunction with a prior acquisition, the Company recorded a fair value adjustment at acquisition related to certain annuity and interest-sensitive liability blocks of business to reflect the cost of the interest guarantees within the in-force liabilities, based on the difference between the guaranteed interest rate and at purchase assumed new money guaranteed interest rate. This adjustment is included in other future policy benefits and claims payable as disclosed in the table below. This liability is remeasured at the end of each period, taking into account changes in the in-force block. Any resulting change in the liability is recorded as a gain (loss) from updating future policy benefits cash flow assumptions, net through the Condensed Consolidated Income Statements. In addition, annuity and life claims liabilities in course of settlement are included in other future policy benefits and claims payable as disclosed in the table below. The following table summarizes the Company’s reserves for future policy benefits and claims payable balances (in millions): 59 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 9. Reserves for Future Policy Benefits and Claims Payable March 31, December 31, 2026 2025 Reserves for future policy benefits Payout Annuities $ 1,156 $ 1,169 Closed Block Life 3,464 3,580 Closed Block Annuity 3,533 3,647 Reserves for future policy benefits 8,153 8,396 Additional liabilities Closed Block Life 1,175 1,195 Other future policy benefits and claims payable 1,378 1,305 Reserves for future policy benefits and claims payable $ 10,706 $ 10,896 The following tables present the roll-forward of components of reserves for future policy benefits (in millions): Present Value of Expected Net Premiums Three Months Ended March 31, Year Ended December 31, 2026 2025 Payout Closed Block Closed Block Payout Closed Block Closed Block Annuities Life Annuity Annuities Life Annuity Balance, beginning of period $ — $ 998 $ — $ — $ 847 $ — Beginning of period cumulative effect of changes in discount rate assumptions — 86 — — 125 — Beginning balance at original discount rate — 1,084 — — 972 — Effect of changes in cash flow assumptions — — — — 232 — Effect of actual variances from expected experience — ( 8 ) — — ( 33 ) — Balance adjusted for variances from expectation — 1,076 — — 1,171 — Issuances — 1 — — 2 — Interest accrual — 10 — — 35 — Net premiums collected — ( 32 ) — — ( 124 ) — Ending balance at original discount rate — 1,055 — — 1,084 — End of period cumulative effect of changes in discount rate assumptions — ( 97 ) — — ( 86 ) — Balance, end of period $ — $ 958 $ — $ — $ 998 $ — For the year ended December 31, 2025, the effect of actual variances from expected experience of $ 33 million was mainly attributed to slightly lower actual premiums versus expected premiums related to our closed block products, which are mostly reinsured, resulting in an immaterial net impact to the reserve balance. 60 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 9. Reserves for Future Policy Benefits and Claims Payable Present Value of Expected Future Policy Benefits Three Months Ended March 31, Year Ended December 31, 2026 2025 Payout Closed Block Closed Block Payout Closed Block Closed Block Annuities Life Annuity Annuities Life Annuity Balance, beginning of period $ 1,169 $ 4,578 $ 3,647 $ 1,095 $ 4,425 $ 3,837 Beginning of period cumulative effect of changes in discount rate assumptions 58 671 157 100 806 255 Beginning balance at original discount rate (including DPL of $ 110 , nil and $ 546 in March 31, 2026, and $ 91 , nil and $ 588 in December 31, 2025 for payout annuities, closed block life and closed block annuity, respectively) 1,227 5,249 3,804 1,195 5,231 4,092 Effect of changes in cash flow assumptions — — — ( 20 ) 414 ( 8 ) Effect of actual variances from expected experience 1 6 2 ( 16 ) ( 30 ) 6 Balance adjusted for variances from expectation 1,228 5,255 3,806 1,159 5,615 4,090 Issuances 30 3 — 171 8 — Interest accrual 12 39 40 47 150 169 Benefits payments ( 43 ) ( 154 ) ( 111 ) ( 150 ) ( 524 ) ( 455 ) Ending balance of original discount rate (including DPL of $ 106 , nil and $ 534 in March 31, 2026, and $ 110 , nil and $ 546 in December 31, 2025 for payout annuities, closed block life and closed block annuity, respectively) 1,227 5,143 3,735 1,227 5,249 3,804 End of period cumulative effect of changes in discount rate assumptions ( 71 ) ( 721 ) ( 202 ) ( 58 ) ( 671 ) ( 157 ) Balance, end of period $ 1,156 $ 4,422 $ 3,533 $ 1,169 $ 4,578 $ 3,647 Reserves for future policy benefits 1,156 3,464 3,533 1,169 3,580 3,647 Less: Reinsurance recoverable 129 1,952 4 128 2,012 4 Reserves for future policy benefits, after reinsurance recoverable $ 1,027 $ 1,512 $ 3,529 $ 1,041 $ 1,568 $ 3,643 The following table presents the weighted average duration of the reserves for future policy benefits. The weighted average duration represents average cohort-level duration weighted by the benefit reserves amount: Payout Closed Block Closed Block Annuities Life Annuity March 31, 2026 Weighted average duration (years) 6.2 6.7 6.4 December 31, 2025 Weighted average duration (years) 6.2 6.8 6.5 The discount rate assumption related to the single-A corporate instrument yield was updated based on current market data. Discount rates increased in 2026 compared to 2025, based on the duration of the liability. This resulted in a decrease in the liability. Refer to the roll-forward above for further details. 61 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 9. Reserves for Future Policy Benefits and Claims Payable The following table presents the amount of undiscounted and discounted expected future gross premiums and expected future benefit payments for future policy benefits for non-participating traditional and limited-payment insurance contracts (in millions). The discounted premiums are calculated using the current discount rate, while the undiscounted cash flows represent the gross cash flows before any discounting is applied: March 31, 2026 December 31, 2025 Undiscounted Discounted Undiscounted Discounted Payout Annuities Expected future benefit payments $ 1,557 $ 1,050 $ 1,547 $ 1,059 Expected future gross premiums — — — — Closed Block Life Expected future benefit payments 6,720 4,540 6,875 4,696 Expected future gross premiums 3,711 2,332 3,810 2,429 Closed Block Annuity Expected future benefit payments 4,530 2,999 4,618 3,101 Expected future gross premiums $ — $ — $ — $ — The following table presents the amount of revenue and interest related to non-participating traditional and limited-pay insurance contracts recognized in the Condensed Consolidated Income Statements (in millions): Gross Premiums Interest Expense Three Months Ended March 31, 2026 Year Ended December 31, 2025 Three Months Ended March 31, 2026 Year Ended December 31, 2025 Payout Annuities $ 6 $ 67 $ 12 $ 47 Closed Block Life 67 295 29 115 Closed Block Annuity 1 ( 2 ) 40 169 Total $ 74 $ 360 $ 81 $ 331 The following table presents the weighted average interest rate for the reserves for future policy benefits at the cohort level for the locked-in discount rate (interest accretion rate), and current discount rate, weighted by the cohort's benefit reserve amount: March 31, 2026 December 31, 2025 Payout Annuities Interest accretion rate 4.29 % 4.26 % Current discount rate 5.36 % 5.10 % Closed Block Life Interest accretion rate 3.08 % 3.08 % Current discount rate 5.51 % 5.31 % Closed Block Annuity Interest accretion rate 4.40 % 4.40 % Current discount rate 5.41 % 5.16 % 62 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 9. Reserves for Future Policy Benefits and Claims Payable The following table presents a roll-forward of Closed Block Life additional liabilities for annuitization, death and other insurance benefits (in millions): Three Months Ended March 31, 2026 Year Ended December 31, 2025 Balance, beginning of period $ 1,195 $ 1,184 Beginning of period cumulative effect of changes in shadow adjustments 14 23 Beginning balance excluding shadow 1,209 1,207 Effect of changes in cash flow assumptions — 5 Effect of actual variances from expected experience 5 33 Interest accrual 14 58 Net assessments collected ( 32 ) ( 94 ) Ending balance excluding shadow 1,196 1,209 End of period cumulative effect of changes in shadow adjustments ( 21 ) ( 14 ) Balance, end of period $ 1,175 $ 1,195 The following table presents the weighted average duration of Closed Block Life additional liabilities for annuitization, death and other insurance benefits. The weighted average duration represents average cohort-level duration weighted by the benefit reserves amount: March 31, 2026 December 31, 2025 Weighted average duration (years) 8.7 8.7 The following table presents assessments and interest expense of Closed Block Life additional liabilities for annuitization, death and other insurance benefits recognized in the Condensed Consolidated Income Statements (in millions): Assessments Interest Expense Three Months Ended March 31, 2026 Year Ended December 31, 2025 Three Months Ended March 31, 2026 Year Ended December 31, 2025 Additional liability for annuitization, death and other insurance benefits $ ( 32 ) $ ( 94 ) $ 14 $ 58 The following table presents the weighted average current discount rate of Closed Block Life additional liabilities for annuitization, death and other insurance benefits, applied at the cohort level weighted by reserve benefit amount: March 31, 2026 December 31, 2025 Weighted average current discount rate 5.00 % 5.00 % 63 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 10. Other Contract Holder Funds 10. Other Contract Holder Funds Other contract holder funds represent the policyholder account balance on our universal life-type products, investment contracts, and the fair value of the embedded derivatives associated with the indexed crediting features on our fixed index annuities and RILA. • Universal life-type products : Universal life-type contracts have, as a principal component, an account balance on which interest is credited to policyholders and assessments are deducted for mortality risk and contract administration. The account balance is recognized as a liability within other contract holder funds, and the liability is updated each period for fee and assessment deductions and increased for interest or returns credited to the account balance. Certain of our universal life-type contracts contain features that are not classified as market risk benefits or embedded derivatives but provide additional benefits beyond the account balance or base insurance coverage for which a liability in addition to the account balance is necessary. These additional liabilities for death or other insurance benefits are reported as a component of reserves for future policy benefits and claims payable in the Condensed Consolidated Balance Sheets. See Note 9 - Reserves for Future Policy Benefits and Claims Payable of these Notes to the Condensed Consolidated Financial Statements for more information regarding these additional liabilities. • Investment contracts : Certain contracts without significant mortality or morbidity risk and certain annuities that lack insurance risk are treated as investment contracts. For investment contracts, payments received are reported as liabilities and accounted for in a manner consistent with the accounting for interest-bearing or other financial instruments, within other contract holder funds. The Company issues a variety of annuity products including variable annuities, registered index linked annuities, fixed annuities, fixed index annuities, and payout annuities. For annuity contracts that are classified as investment contracts, the liability is the account balance as of the reporting date, reported within the other contract holder funds. For the variable annuity products, only the allocations to fixed fund options are reported in other contract holder funds. • Embedded derivatives - product liabilities : For our RILA and fixed index annuities, the equity-linked option issued by the Company is accounted for at fair value as an embedded derivative on the Company's Condensed Consolidated Balance Sheets as a component of other contract holder funds, with changes in fair value recorded in net income. The fair value of the embedded derivative for the FIA and RILA products is determined using an option-budget method with capital market inputs of market index returns and discount rates as well as actuarial assumptions including lapse, mortality and withdrawal rates. We typically update our actuarial assumptions annually, unless a material change is observed in an interim period that we feel is indicative of a long-term trend. Our annuity products may contain certain features or guarantees that are classified as MRBs. These market risk benefits are a component of the market risk benefits line items in the Condensed Consolidated Balance Sheets. See Note 12 - Market Risk Benefits of these Notes to Condensed Consolidated Financial Statements for more information regarding market risk benefits. 64 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 10. Other Contract Holder Funds The Company’s institutional products business is comprised of the guaranteed investment contracts, funding agreements backed by medium-term notes ("FABN funding agreements"), funding agreements backed by commercial paper ("FABCP funding agreements"), and funding agreements issued in conjunction with the Company's participation in the U.S. Federal Home Loan Bank ("FHLB") program ("FHLB funding agreements") described below. • FABN funding agreements: Jackson has established a funding agreement-backed note (“FABN”) program, pursuant to which a special purpose statutory business trust may issue medium-term notes and deposit the proceeds with Jackson pursuant to a funding agreement issued by Jackson to the trust. As of March 31, 2026, there was remaining authority to issue up to $ 4.1 billion of medium-term notes under the program. The carrying values of the FABN funding agreements at March 31, 2026 and December 31, 2025 totaled $ 7.5 billion and $ 8.0 billion, respectively. Liabilities for foreign currency denominated FABN funding agreements are adjusted to reflect the effects of foreign currency translation gains and losses using exchange rates as of the reporting date. Foreign currency translation gains and losses are included in net gains (losses) on derivatives and investments. FABN funding agreements issued in a foreign currency have been hedged for changes in exchange rates using cross-currency swaps. • FABCP funding agreements: In the second quarter of 2025, Jackson established an FABCP funding agreement program, pursuant to which a special purpose limited liability company may issue commercial paper and deposit the proceeds with Jackson under funding agreements issued by Jackson to the limited liability company. The current maximum aggregate principal amount permitted to be outstanding at any one time under the program is $ 3.0 billion. As of March 31, 2026, the Company had $ 1.3 billion outstanding under the program. • FHLB funding agreements: Jackson is a member of the FHLBI primarily for the purpose of participating in the bank’s mortgage-collateralized loan advance program with long-term funding facilities. Advances are in the form of funding agreements issued to, and short-term and long-term borrowings from, FHLBI. At both March 31, 2026 and December 31, 2025, the Company held $ 119 million of FHLBI capital stock, respectively, supporting $ 1.9 billion in FHLB funding agreements and short-term and long-term borrowings at both March 31, 2026 and December 31, 2025. At both March 31, 2026 and December 31, 2025, the FHLB funding agreements and short-term and long-term borrowings were collateralized by mortgage-related securities and commercial mortgage loans with a carrying value of $ 2.8 billion. The following table presents the liabilities for other contract holder funds (in millions): March 31, 2026 December 31, 2025 Variable Annuity $ 6,193 $ 6,351 RILA 21,394 20,282 Fixed Annuity 9,300 9,494 Fixed Index Annuities 8,255 7,946 Payout Annuity 840 854 Closed Block Life 10,381 10,494 Closed Block Annuity 1,035 1,057 Institutional Products 11,141 11,021 Other Product Lines 164 164 Total other contract holder funds $ 68,703 $ 67,663 65 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 10. Other Contract Holder Funds The following table presents a roll-forward of other contract holder funds, gross of reinsurance (in millions): Fixed Closed Closed Variable Fixed Index Payout Block Block Annuity RILA Annuity Annuities Annuity Life Annuity Total Balance as of January 1, 2026 $ 6,351 $ 20,282 $ 9,494 $ 7,946 $ 854 $ 10,494 $ 1,057 $ 56,478 Deposits 196 2,010 89 677 45 66 1 3,084 Surrenders, withdrawals and benefits ( 516 ) ( 164 ) ( 343 ) ( 341 ) ( 66 ) ( 207 ) ( 32 ) ( 1,669 ) Net transfers from (to) separate accounts 134 — — — — — — 134 Investment performance / change in value of equity option — ( 757 ) — ( 17 ) — — — ( 774 ) Interest credited 39 22 89 40 7 156 9 362 Policy charges and other ( 11 ) 1 ( 29 ) ( 50 ) — ( 128 ) — ( 217 ) Balance as of March 31, 2026 $ 6,193 $ 21,394 $ 9,300 $ 8,255 $ 840 $ 10,381 $ 1,035 $ 57,398 Fixed Closed Closed Variable Fixed Index Payout Block Block Annuity RILA Annuity Annuities Annuity Life Annuity Total Balance as of January 1, 2025 $ 7,206 $ 11,685 $ 9,615 $ 8,515 $ 844 $ 10,750 $ 1,149 $ 49,764 Deposits 855 6,926 1,085 816 220 272 3 10,177 Surrenders, withdrawals and benefits ( 2,204 ) ( 399 ) ( 1,392 ) ( 1,596 ) ( 238 ) ( 655 ) ( 132 ) ( 6,616 ) Net transfers from (to) separate accounts 372 — — — — — — 372 Investment performance / change in value of equity option — 2,002 — 156 — — — 2,158 Interest credited 182 66 350 150 28 631 38 1,445 Policy charges and other ( 60 ) 2 ( 164 ) ( 95 ) — ( 504 ) ( 1 ) ( 822 ) Balance as of December 31, 2025 $ 6,351 $ 20,282 $ 9,494 $ 7,946 $ 854 $ 10,494 $ 1,057 $ 56,478 The following table presents weighted average crediting rate, net amount at risk, and cash surrender value of contract holder account balances (dollars in millions): Fixed Closed Closed Variable Fixed Index Payout Block Block Annuity RILA Annuity Annuities Annuity Life Annuity March 31, 2026 Weighted-average crediting rate (1) 2.52 % 0.41 % 3.83 % 1.94 % 3.33 % 6.01 % 3.48 % Net amount at risk (2) $ — $ — $ — $ — $ — $ 14,592 $ — Cash surrender value (3) $ 6,190 $ 20,861 $ 9,087 $ 8,059 $ — $ 10,332 $ 1,035 December 31, 2025 Weighted-average crediting rate (1) 2.87 % 0.33 % 3.69 % 1.89 % 3.28 % 6.01 % 3.60 % Net amount at risk (2) $ — $ — $ — $ — $ — $ 14,750 $ — Cash surrender value (3) $ 6,330 $ 19,736 $ 9,277 $ 7,711 $ — $ 10,445 $ 1,057 (1) Weighted average crediting rate is the average crediting rate weighted by contract holder account balances invested in fixed account funds. (2) Net amount at risk represents the standard excess benefit base for guaranteed death benefits on universal life type products. The net amount at risk associated with market risk benefits are presented within Note 12 - Market Risk Benefits of these Notes to Condensed Consolidated Financial Statements. (3) Cash surrender value represents the amount of the contract holder’s account balance distributable at the balance sheet date less the applicable surrender charges. 66 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 10. Other Contract Holder Funds At March 31, 2026 and December 31, 2025, excluding reinsurance business, approximately 92 % and 93 %, respectively, of the Company’s annuity account values correspond to crediting rates that are at the minimum guaranteed interest rates. At March 31, 2026 and December 31, 2025, excluding reinsurance business, approximately 82 % and 82 %, respectively, of the Company’s closed block life account values correspond to crediting rates that are at the minimum guaranteed interest rates. The following table presents contract holder account balances invested in fixed account funds by range of guaranteed minimum crediting rates and the related range of the difference between rates being credited to other contract holder funds and the respective guaranteed minimums (in millions): March 31, 2026 At Guaranteed 1 Basis Point- 50 51 Basis Points- 150 Greater Than 150 Range of Guaranteed Minimum Crediting Rate Minimum Basis Points Above Basis Points Above Basis Points Above Total Variable Annuities 0.00 %- 1.50 % $ — $ — $ — $ — $ — 1.51 %- 2.50 % 4,153 — 125 — 4,278 Greater than 2.50 % 1,915 — — — 1,915 Total $ 6,068 $ — $ 125 $ — $ 6,193 RILA 0.00 %- 1.50 % $ 5 $ — $ 3 $ 3 $ 11 1.51 %- 2.50 % — — 24 — 24 Greater than 2.50 % 113 109 — — 222 Total $ 118 $ 109 $ 27 $ 3 $ 257 Fixed Annuities 0.00 %- 1.50 % $ 24 $ 31 $ 11 $ 1 $ 67 1.51 %- 2.50 % 18 1 41 4 64 Greater than 2.50 % 3,029 32 — 277 3,338 Total $ 3,071 $ 64 $ 52 $ 282 $ 3,469 Fixed Index Annuities 0.00 %- 1.50 % $ 3 $ 11 $ 2 $ 27 $ 43 1.51 %- 2.50 % — 24 — 12 36 Greater than 2.50 % 34 5 82 46 167 Total $ 37 $ 40 $ 84 $ 85 $ 246 Closed Block Life 0.00 %- 1.50 % $ — $ — $ — $ — $ — 1.51 %- 2.50 % 1 10 — — 11 Greater than 2.50 % 5,189 382 709 5 6,285 Total $ 5,190 $ 392 $ 709 $ 5 $ 6,296 Closed Block Annuity 0.00 %- 1.50 % $ — $ — $ — $ — $ — 1.51 %- 2.50 % — — 1 11 12 Greater than 2.50 % 850 17 24 — 891 Total $ 850 $ 17 $ 25 $ 11 $ 903 67 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 10. Other Contract Holder Funds December 31, 2025 At Guaranteed 1 Basis Point- 50 51 Basis Points- 150 Greater Than 150 Range of Guaranteed Minimum Crediting Rate Minimum Basis Points Above Basis Points Above Basis Points Above Total Variable Annuities 0.00 %- 1.50 % $ — $ — $ — $ — $ — 1.51 %- 2.50 % 137 — — — 137 Greater than 2.50 % 6,113 101 — — 6,214 Total $ 6,250 $ 101 $ — $ — $ 6,351 RILA 0.00 %- 1.50 % $ 5 $ — $ 3 $ 3 $ 11 1.51 %- 2.50 % — — — — — Greater than 2.50 % 136 93 — — 229 Total $ 141 $ 93 $ 3 $ 3 $ 240 Fixed Annuities 0.00 %- 1.50 % $ 25 $ 37 $ 12 $ 28 $ 102 1.51 %- 2.50 % 16 1 1 — 18 Greater than 2.50 % 3,001 33 — 278 3,312 Total $ 3,042 $ 71 $ 13 $ 306 $ 3,432 Fixed Index Annuities 0.00 %- 1.50 % $ 3 $ 11 $ 2 $ 28 $ 44 1.51 %- 2.50 % — — — — — Greater than 2.50 % 36 — 86 53 175 Total $ 39 $ 11 $ 88 $ 81 $ 219 Closed Block Life 0.00 %- 1.50 % $ — $ — $ — $ — $ — 1.51 %- 2.50 % 1 10 — — 11 Greater than 2.50 % 5,251 388 720 5 6,364 Total $ 5,252 $ 398 $ 720 $ 5 $ 6,375 Closed Block Annuity 0.00 %- 1.50 % $ — $ — $ — $ — $ — 1.51 %- 2.50 % — — 1 11 12 Greater than 2.50 % 872 18 24 — 914 Total $ 872 $ 18 $ 25 $ 11 $ 926 68 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 11. Separate Account Assets and Liabilities 11. Separate Account Assets and Liabilities The Company issues variable contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contract holder (traditional variable annuities). The Company also issues variable contracts through separate accounts where the Company contractually guarantees to the contract holder (variable contracts with guarantees) the following: a) return of no less than total deposits made to the account adjusted for any partial withdrawals, b) total deposits made to the account adjusted for any partial withdrawals plus a minimum return, or c) the highest account value on a specified anniversary date adjusted for any withdrawals following the contract anniversary. These guarantees include benefits that are payable in the event of death (guaranteed minimum death benefits, or "GMDB"), at annuitization (guaranteed minimum income benefits, or "GMIB"), upon the depletion of funds (guaranteed minimum withdrawal benefits, or "GMWB") or at the end of a specified period (guaranteed minimum accumulation benefits, or "GMAB"). These guarantees are classified as market risk benefits. See Note 12 - Market Risk Benefits of these Notes to Condensed Consolidated Financial Statements for more information regarding market risk benefits. The separate account assets supporting the variable portion of both traditional variable annuities and variable contracts with guarantees are carried at fair value and reported as summary total separate account assets with an equivalent summary total reported for separate account liabilities. At March 31, 2026 and December 31, 2025, the assets and liabilities associated with variable life and annuity contracts were $ 223 billion and $ 236 billion, respectively. Investment risks associated with market value changes are borne by the contract holders, except to the extent of minimum guarantees made by the Company. Separate account net investment income, net investment realized and unrealized gains and losses, and the related liability changes are offset within the same line item in the Condensed Consolidated Income Statements. Amounts assessed against the contract holders for mortality, variable annuity benefit guarantees, administrative, and other services are reported in revenue as fee income. The following table presents the roll-forward of the separate account balance for variable annuities (in millions): Three Months Ended March 31, 2026 Year Ended December 31, 2025 Balance as of beginning of period $ 236,406 $ 228,851 Deposits (1) 2,317 9,998 Surrenders, withdrawals and benefits (1) ( 6,955 ) ( 27,633 ) Net transfer from (to) general account ( 134 ) ( 372 ) Investment performance ( 7,603 ) 28,278 Policy charges and other ( 666 ) ( 2,716 ) Balance as of end of period, gross $ 223,365 $ 236,406 Cash surrender value (2) $ 218,733 $ 231,711 (1) Excludes certain internal exchanges. (2) Cash surrender value represents the amount of the contract holder’s account balances distributable at the balance sheet date less applicable surrender charges. The following table presents the reconciliation of the separate account balance in the Condensed Consolidated Balance Sheets (in millions): March 31, 2026 December 31, 2025 Variable Annuities $ 223,365 $ 236,406 Other Product Lines 87 90 Total $ 223,452 $ 236,496 69 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 11. Separate Account Assets and Liabilities Included in the separate account balance of Other Product Lines above are separate account assets related to a Jackson-issued group variable annuity contract designed for use in connection with and issued to the Company’s Defined Contribution Retirement Plan ("the Plan"). During 2025, the Plan withdrew all assets held under this variable annuity contract and transferred them to other investment options under the Plan. At both March 31, 2026 and December 31, 2025, separate account assets and separate account liabilities related to this variable annuity contract are nil . The following table presents aggregate fair value of assets, by major investment asset category, supporting separate accounts (in millions): March 31, 2026 December 31, 2025 Variable Annuities By Fund Type Equity $ 160,973 $ 171,046 Bond 19,110 19,711 Balanced 40,841 43,317 Money Market 2,441 2,332 Total Variable Annuities 223,365 236,406 Other Product Lines 87 90 Total Separate Accounts $ 223,452 $ 236,496 12. Market Risk Benefits Contracts or contract features that provide protection to the contract holder from capital market risk and expose the Company to other-than-nominal capital market risk are classified as MRBs. All long-duration insurance contracts and certain investment contracts are subject to MRB evaluation. MRBs are measured at fair value at the contract level and can be in either an asset or liability position. For contracts that contain multiple MRB features, the MRBs are valued together as a single compound MRB. Market risk benefit assets and Market risk benefit liabilities are reported separately on the Condensed Consolidated Balance Sheets. Changes in fair value are reported in Net (gains) losses on market risk benefits in the Condensed Consolidated Income Statements. However, the change in fair value related to our own non-performance risk is reported as a component of other comprehensive income in Change in non-performance risk on market risk benefits on the Condensed Consolidated Statements of Comprehensive Income (Loss). A description of the items affecting the change in fair value by category is as follows: • Changes in interest rates — movement in risk free rates (impacts both assumed future separate account returns and discounting of cash flows) • Fund performance — separate account returns gross of fees • Change in equity index volatility — movement in implied volatility • Expected policyholder behavior — policyholder behavior as assumed in reserving • Actual policyholder behavior different than expected — difference between actual behavior during the period versus assumed behavior • Time — effect of passage of time including reduction to separate account balances from fees, the change in proximity of future cash flows, and impacts to policy features such as bonus credits • Change in assumptions — effect of actuarial assumption updates and model enhancements • Change in non-performance risk — changes in Jackson’s non-performance risk See Note 6 - Fair Value Measurements of these Notes to Condensed Consolidated Financial Statements for more information regarding fair value measurements. Additionally, when an annuitization occurs (for annuitization benefits) or upon extinguishment of the account balance (for withdrawal benefits), the balance related to the MRB is derecognized and the amount deducted (after derecognition of any related amount included in accumulated other comprehensive income) is used in the calculation of the liability for future policy benefits for the resulting payout annuity. 70 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 12. Market Risk Benefits Variable Annuities Variable annuity contracts issued by the Company offer various guaranteed minimum death, withdrawal, income and accumulation benefits. These guaranteed benefit features, as well as the reinsurance recoverable on the Company’s GMIB, are classified as MRBs and measured at fair value. The Company discontinued offering the GMIB in 2009. Variable annuity guaranteed benefit features classified as MRBs, which have explicit fees, are measured using the attributed fee method. Under the attributed fee method, fair value is measured as the difference between the present value of projected future liabilities and the present value of projected attributed fees. At the inception of the contract, the Company attributes to the MRB a portion of total fees expected to be assessed against the contract holder to offset the projected claims over the lifetime of the contract. The attributed fee is expressed as a percentage of total projected future fees at inception of the contract. This percentage of total projected fees is considered a fixed term of the MRB feature and is held static over the life of the contract. This percentage may not exceed 100% of the total projected contract fees as of contract inception. As the Company may issue contracts that have projected future liabilities greater than the projected future guaranteed benefit fees at issue, the Company may also attribute mortality and expense charges when performing this calculation. In subsequent valuations, the present value of both future projected liabilities and projected attributed fees are remeasured based on current market conditions and policyholder behavior assumptions. Fixed Index Annuities and RILA Our FIA and RILA contracts may be issued with features that guarantee benefits that are payable upon death (GMDB) or upon depletion of funds (GMWB). These features are classified as MRBs and measured at fair value. Where the guaranteed benefit features have explicit fees, the fair value of the MRB is measured as the difference between the present value of projected future guaranteed benefits and the present value of projected attributed fees (the attributed fee method). At inception of the contract, the Company attributes a percentage of total projected future fees expected to be assessed against the policyholder to offset the projected future guaranteed benefits over the lifetime of the contract. Where the projected attributed fees are sufficient to offset the projected guaranteed benefits at issue, the MRB has an initial fair value of zero resulting in no gain or loss on issuance of the contract. If the projected attributed fees are insufficient to offset the projected guaranteed benefits at issue, an MRB liability is recognized at issuance and the value of the MRB is deducted from the host contract liability resulting in no gain or loss on issuance of the contract. If the guaranteed benefits do not have explicit fees, the fair value of the MRB is measured as the present value of projected future guaranteed benefits. At inception, the initial value of the MRB is deducted from the host contract liability resulting in no gain or loss on issuance of the contract. The following table presents the reconciliation of the market risk benefits balance in the Condensed Consolidated Balance Sheets (in millions): March 31, 2026 December 31, 2025 Variable Other Variable Other Annuities Product Lines Total Annuities Product Lines Total Market risk benefit - (assets) $ ( 6,698 ) $ ( 3 ) $ ( 6,701 ) $ ( 7,863 ) $ ( 4 ) $ ( 7,867 ) Market risk benefit - liabilities 3,764 207 3,971 3,598 156 3,754 Market risk benefit - net (asset) liability $ ( 2,934 ) $ 204 $ ( 2,730 ) $ ( 4,265 ) $ 152 $ ( 4,113 ) 71 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 12. Market Risk Benefits The following table presents the roll-forward of the net MRB (assets) liabilities for variable annuities (dollars in millions): Three Months Ended March 31, 2026 Year Ended December 31, 2025 Net MRB balance, beginning of period $ ( 4,265 ) $ ( 5,176 ) Beginning of period cumulative effect of changes in non-performance risk ( 17 ) 314 Net MRB balance, beginning of period, before effect of changes in non-performance risk ( 4,282 ) ( 4,862 ) Effect of changes in interest rates ( 407 ) ( 72 ) Effect of fund performance 671 ( 3,518 ) Effect of changes in equity index volatility 551 509 Effect of expected policyholder behavior 215 758 Effect of actual policyholder behavior different from expected 110 572 Effect of time 508 1,957 Effect of changes in assumptions 3 374 Net MRB balance, end of period, before effect of changes in non-performance risk ( 2,631 ) ( 4,282 ) End of period cumulative effect of changes in non-performance risk ( 303 ) 17 Net MRB balance, end of period, gross ( 2,934 ) ( 4,265 ) Reinsurance recoverable on market risk benefits at fair value, end of period ( 43 ) ( 41 ) Net MRB balance, end of period, net of reinsurance ( 2,977 ) ( 4,306 ) Weighted average attained age (years) (1) 71 70 Net amount at risk (2) $ 7,193 $ 5,471 (1) Weighted-average attained age is defined as the average age of policyholders weighted by account value. (2) Net amount at risk (NAR) is defined as of the valuation date for each contract as the greater of Death Benefit NAR (DBNAR) and Living Benefit NAR (LBNAR), as applicable, where DBNAR is the GMDB benefit base in excess of the account value, and LBNAR is the actuarial present value of guaranteed living benefits in excess of the account value. The Company regularly evaluates the inputs and assumptions to be used to measure the fair value of the MRB assets and MRB liabilities. Non-performance risk is incorporated into the calculation through the adjustment of the risk-free rate curve based on credit spreads for debt and debt-like instruments issued by the Company or its insurance operating subsidiaries, adjusted, as necessary, to reflect the financial strength ratings of the issuing insurance subsidiaries. The significant assumptions used in the MRB fair value calculations are discussed in Note 6 - Fair Value Measurements of these Notes to Condensed Consolidated Financial Statements. 13. Long-Term Debt Liabilities for the Company’s debt are primarily carried at an amount equal to the principal balance net of any unamortized original issuance discount or premium. Original issuance discount or premium and any debt issue costs, if applicable, are recognized as a component of interest expense over the period the debt is expected to be outstanding. The aggregate carrying value of long-term debt was as follows (in millions): March 31, December 31, 2026 2025 Long-Term Debt 5.170 % Senior Notes due 2027 $ 399 $ 399 3.125 % Senior Notes due 2031 497 496 5.670 % Senior Notes due 2032 348 348 4.000 % Senior Notes due 2051 490 490 Surplus notes due 2027 250 250 FHLBI bank loans due 2034 & 2035 43 47 Total long-term debt $ 2,027 $ 2,030 72 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 13. Long-Term Debt The following table presents the contractual maturities of the Company's long-term debt as of March 31, 2026 (in millions): Calendar Year 2027 2028 2029 2030 2031 and thereafter Total Long-term debt $ 649 $ — $ — $ — $ 1,378 $ 2,027 Facility Agreement for Senior Notes Issuance In March 2026, the Company entered into: • a 10-year facility agreement with a Delaware trust in connection with that trust’s sale of $ 500 million of pre-capitalized trust securities; and • a 30-year facility agreement with a separate Delaware trust in connection with that trust’s sale of $ 400 million of pre-capitalized trust securities. The pre-capitalized trust securities were issued and sold in a private placement pursuant to Rule 144A under the Securities Act. Each trust invested the proceeds from the sale of its trust securities in a portfolio of principal and/or interest strips of U.S. Treasury securities. Each facility agreement provides the Company with the right to issue and sell to the applicable trust from time to time the Company’s unsecured senior notes, consisting of up to $ 500 million of 6.311 % senior notes due February 15, 2036 (the "2036 Senior Notes"), in case of the 10-year facility agreement, and up to $ 400 million of 7.280 % senior notes due February 15, 2056 (the "2056 Senior Notes"), in case of the 30-year facility agreement, in exchange for a corresponding amount of the U.S. Treasury securities held by the applicable trust. The U.S. Treasury securities held by a trust are pledged to the Company as collateral securing that trust’s performance under its facility agreement. The Company may direct a trust to grant the right to exercise the issuance right with respect to all or a designated amount of the applicable senior notes to one or more assignees (who are our consolidated subsidiaries or persons to whom we have an obligation). The issuance right under a facility agreement will be exercised automatically in full upon the Company’s failure to make certain payments to the applicable trust or upon certain bankruptcy events involving the Company. The Company is also required to exercise this issuance right if its consolidated stockholders’ equity, calculated in accordance with U.S. GAAP but excluding accumulated other comprehensive income and equity of non-controlling interests, falls below $ 2.8 billion, subject to adjustment from time to time in certain cases, and upon certain other events described in the applicable facility agreement. Prior to any involuntary exercise of the issuance right under a facility agreement, the Company has the right to repurchase any or all of the senior notes then held by the applicable trust in exchange for U.S. Treasury securities. The Company may redeem any outstanding senior notes issued to a trust, in whole or in part, prior to their maturity at a redemption price equal to the greater of par or a make-whole redemption price. On or after their maturities, the senior notes may be redeemed at par. The Company is required to purchase from a trust any U.S. Treasury securities that are due and unpaid at an amount equal to their face amount. The Company pays a semi-annual facility fee under the 10-year facility agreement and the 30-year facility agreement to the applicable trust at a rate of 2.066 % and 2.430 % per annum, respectively, applied to the maximum amount of senior notes that the Company could issue and sell to that trust, and reimburses each trust for its expenses under separate expense agreements. The facility fees and expense reimbursements are recorded in operating costs and other expenses. At March 31, 2026, the Company had not issued any senior notes under either facility agreement. The Company incurred $ 7 million of origination costs, which were capitalized and reported in other assets and will be amortized over the terms of the respective facility agreements. 73 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 13. Long-Term Debt Revolving Credit Facility The Company has a revolving credit facility (the "Revolving Credit Facility") with a syndicate of banks and Bank of America, N.A., as Administrative Agent. The Revolving Credit Facility provides for borrowings for working capital and other general corporate purposes under aggregate commitments of $ 1.0 billion, with a sub-limit of $ 500 million available for letters of credit. The Revolving Credit Facility further provides for the ability to request, subject to customary terms and conditions, an increase in commitments thereunder by up to an additional $ 500 million. The credit agreement for the Revolving Credit Facility contains financial maintenance covenants, including a minimum adjusted consolidated net worth test of no less than 70 % of our adjusted consolidated net worth as of September 30, 2022 (plus (to the extent positive) or minus (to the extent negative) 70 % of the impact on such adjusted consolidated net worth resulting from the application of the one-time transition adjustment for the LDTI accounting change for insurance contracts, and plus 50 % of the aggregate amount of any increase in adjusted consolidated net worth resulting from equity issuances by the Company and its consolidated subsidiaries after September 30, 2022), and a maximum consolidated indebtedness to total capitalization ratio test not to exceed 35 %. Commitments under the Revolving Credit Facility terminate on February 24, 2028. Line of Credit Agreement Jackson is a party to an Uncommitted Money Market Line Credit Agreement, among Jackson, Jackson Financial, and Société Générale. This agreement is an uncommitted short-term cash advance facility that provides an additional form of liquidity to Jackson and to Jackson Financial. The aggregate borrowing capacity under the agreement is $ 500 million and each cash advance request must be at least $ 100 thousand. The interest rate is set by the lender at the time of the borrowing and is fixed for the duration of the advance. Jackson and Jackson Financial are jointly and severally liable to repay any advance under the agreement, which must be repaid prior to the last day of the quarter in which the advance was drawn. 14. Federal Home Loan Bank Advances The Company, through its subsidiary, Jackson, entered into an advance program with the FHLBI in which interest rates were either fixed or variable based on the FHLBI cost of funds or market rates. No advances were outstanding at March 31, 2026 and December 31, 2025. Interest expense on such advances was nil and $ 4 million for the three months ended March 31, 2026 and 2025, respectively. See Note 10 - Other Contract Holder Funds of these Notes to Condensed Consolidated Financial Statements for the carrying value of securities pledged as collateral for our FHLB obligations . 15. Income Taxes The Company uses the estimated annual effective tax rate (“ETR”) method in computing the interim tax provision. Certain items, including those deemed unusual, infrequent, or that cannot be reliably estimated, are treated as discrete items and excluded from the estimated annual ETR. In these cases, the actual tax expense or benefit is reported in the same period as the related item. Certain tax effects are also not reflected in the estimated annual ETR, primarily certain changes in the realizability of deferred tax assets and uncertain tax positions and are recorded in the period in which the change occurs. The estimated annual ETR is revised, as necessary, at the end of successive interim reporting periods. The Company's effective income tax rate was ( 4.9 )% for the three months ended March 31, 2026 compared with ( 5.9 )% for the same period in 2025, respectively. The ETR, excluding significant unusual or infrequently occurring items, differs from the statutory rate of 21% primarily due to the dividends received deduction and utilization of foreign tax credits. The ETR differs for the three months ended March 31, 2026 from the full year-ended December 31, 2025 ETR of 117.0 % due to the relationship of taxable income to consolidated pre-tax income (loss), valuation allowance, the variance of the impact of tax adjustments related to prior year returns and the benefit of IRS refund interest on carryback claims and amended returns both recognized in 2025. 74 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 15. Income Taxes For the three months ended March 31, 2026 and 2025, the Company recorded nil for the provision of the corporate alternative minimum tax ("CAMT") with an offsetting increase to the deferred tax asset for the credit carryover resulting in no impact to total tax expense. The determination of the estimated 2026 CAMT liability considered carryover impacts from prior tax years and consideration of the applicability of the proposed regulations and additional guidance issued by the Internal Revenue Service. The U.S. Treasury Department is expected to issue additional guidance in 2026 or later that may materially change the estimated provision of the CAMT. The Company is required to evaluate the recoverability of its deferred tax assets and establish a valuation allowance, if necessary, to reduce its deferred tax asset to an amount that is more likely than not to be realizable. Considerable judgment and the use of estimates are required when determining whether a valuation allowance is necessary and, if so, the amount of such valuation allowance. When evaluating the need for a valuation allowance, the Company considers many factors, including: the nature and character of the deferred tax assets and liabilities; taxable income in prior carryback years; future reversals of temporary differences; the length of time carryovers can be utilized; and any tax planning strategies the Company would employ to avoid a tax benefit from expiring unused. The Company has adopted an accounting policy to analyze the ability to recover the CAMT credit carryover deferred tax asset separately from the deferred tax assets generated under the regular tax system. For the three months ended March 31, 2026, changes in market conditions and interest rates impacted the unrealized tax gains and losses in the available-for-sale securities portfolio resulting in deferred tax assets related to net unrealized tax capital losses for the life insurance group. The deferred tax asset relates to the unrealized losses for which the carryforward period has not yet begun, and as such, when assessing its recoverability, we consider our ability and intent to hold the underlying securities to recovery, our capital loss carryback capacity, along with reversing capital deferred tax liabilities. As of March 31, 2026, based on all available evidence, we concluded that a valuation allowance should be established on a portion of the deferred tax asset related to unrealized losses and the charitable contributions carryover that are not more likely than not to be realized. For the three months ended March 31, 2026, the Company recorded a increase of $ 125 million to the valuation allowance associated with the unrealized tax losses in the Company’s available-for-sale securities portfolio, and recorded an increase of $ 1 million for the charitable contributions carryover. The $ 126 million increase for the three months ended March 31, 2026 to the valuation allowance consists of $ 126 million tax expense recorded to other comprehensive income. At March 31, 2026 and December 31, 2025, the Company has recorded a total valuation allowance for $ 612 million and $ 486 million, respectively, associated with the unrealized tax losses in the Life Companies' available-for-sale securities portfolio and the charitable contributions carryover where it is not more likely than not that the full tax benefit of the losses will be realized. 16. Commitments and Contingencies The Company and its subsidiaries are involved in litigation arising in the ordinary course of business. It is the opinion of management that the ultimate disposition of such litigation will not have a material adverse effect on the Company's financial condition. Jackson has been named in civil litigation proceedings, which appear to be substantially similar to other class action litigation brought against many life insurers including allegations of misconduct in the sale and administration of insurance products. The Company accrues for legal contingencies once the contingency is deemed to be probable and reasonably estimable. At March 31, 2026, the Company had unfunded commitments related to its investments in limited partnerships and limited liability companies totaling $ 676 million. At March 31, 2026, unfunded commitments related to fixed-rate mortgage loans and other debt securities totaled $ 794 million. 75 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 17. Operating Costs and Other Expenses 17. Operating Costs and Other Expenses The following table summarizes the Company’s operating costs and other expenses (in millions): Three Months Ended March 31, 2026 2025 Asset-based commission expenses $ 295 $ 284 Other commission expenses 322 215 Sub-advisor expenses 74 78 General and administrative expenses (1) 299 259 Deferral of acquisition costs ( 255 ) ( 159 ) Total operating costs and other expenses $ 735 $ 677 (1) Includes gains (losses) on derivative instruments economically hedging liabilities related to the non-qualified voluntary deferred compensation plan beginning in the third quarter 2025. 18. Accumulated Other Comprehensive Income (Loss) The following table represents changes in the balance of accumulated other comprehensive income ("AOCI"), net of income tax, related to unrealized investment gains (losses) (in millions): Three Months Ended March 31, 2026 2025 Balance, beginning of period (1) $ ( 2,470 ) $ ( 3,522 ) Change in unrealized gains (losses) of investments ( 575 ) 641 Change in current discount rate - reserve for future policy benefits (2) 73 ( 75 ) Change in non-performance risk on market risk benefits 333 327 Change in unrealized gains (losses) - other 7 ( 4 ) Change in deferred tax asset ( 90 ) ( 93 ) Other comprehensive income (loss) before reclassifications ( 252 ) 796 Reclassifications from AOCI, net of tax ( 6 ) 7 Other comprehensive income (loss) ( 258 ) 803 Balance, end of period (1) $ ( 2,728 ) $ ( 2,719 ) (1) Includes $( 1,319 ) million and $( 1,269 ) million related to the investments held within the funds withheld account related to the Athene Reinsurance Transaction as of March 31, 2026 and December 31, 2025, respectively. (2) Represents the impact of changes in the discount rate used in the remeasurement of our direct reserves for future policy benefits and claims payable, net of the remeasurement of ceded reserves for future policy benefits and claims payable. The following table represents amounts reclassified out of AOCI (in millions): AOCI Components Amounts Reclassified from AOCI Affected Line Item in the Condensed Consolidated Income Statements Three Months Ended March 31, 2026 2025 Net unrealized investment gain (loss): Net realized gain (loss) on investments $ 18 $ 24 Net gains (losses) on derivatives and investments Other impaired securities ( 24 ) ( 15 ) Net gains (losses) on derivatives and investments Net unrealized gain (loss) ( 6 ) 9 Income tax expense (benefit) — 2 Reclassifications, net of income taxes $ ( 6 ) $ 7 76 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 19. Equity 19. Equity Preferred Stock On March 13, 2023, the Company issued and sold 22,000,000 depositary shares (the “Depositary Shares”), each representing a 1/1,000th fractional interest in a share of the Company’s Fixed-Rate Reset Noncumulative Perpetual Preferred Stock, Series A, $ 25,000 liquidation preference per share (equivalent to $ 25 per Depositary Share), with a 5-year dividend rate reset period and noncumulative dividends (the “Series A Preferred Stock”). After underwriting discounts and expenses, we received net proceeds of approximately $ 533 million. The Series A Preferred Stock carries a dividend rate equal to i) from issuance to but excluding March 30, 2028, 8.000 % per annum; and ii) from, and including, March 30, 2028, during each reset period, at a rate per annum equal to the Five-year U.S. Treasury Rate as of the applicable reset dividend determination date plus 3.728 %. The dividend is payable quarterly in arrears on March 30, June 30, September 30 and December 30, and commenced on June 30, 2023. Dividends on the Series A Preferred Stock are not cumulative. Under the terms of the Series A Preferred Stock, if the Company has not declared and paid, or declared and set aside a sum sufficient for the payment of, dividends on the Series A Preferred Stock for the immediately preceding dividend period, then the Company’s ability to pay dividends or make distributions with respect to its common stock, or to repurchase or otherwise acquire its common stock, is subject to certain restrictions. Similar restrictions would apply in respect of any preferred stock ranking on parity with, or junior to, the Series A Preferred Stock, if any such preferred stock were to be issued by the Company. We may, at our option, redeem the shares of Series A Preferred Stock (a) in whole but not in part at any time prior to March 30, 2028, (i) within 90 days after the occurrence of a “rating agency event” at a redemption price equal to $ 25,500 per share (equivalent to $ 25.50 per Depositary Share), plus an amount equal to any accrued but unpaid dividends to, but excluding, the redemption date, or (ii) within 90 days after the occurrence of a “regulatory capital event,” at a redemption price equal to $ 25,000 per share (equivalent to $ 25 per Depositary Share), plus an amount equal to any accrued but unpaid dividends to, but excluding, the redemption date, or (b) in whole or in part, from time to time, on or after March 30, 2028, at a redemption price equal to $ 25,000 per share (equivalent to $ 25 per Depositary Share), plus an amount equal to any accrued but unpaid dividends to, but excluding, the redemption date. If we redeem any shares of Series A Preferred Stock, a proportionate number of Depositary Shares will be redeemed. Holders of Depositary Shares have no right to require the redemption or repurchase of the Series A Preferred Stock or the Depositary Shares. The net proceeds from the sale were used for general corporate purposes, including the repayment of senior notes that matured in November 2023. The following table presents the declaration date, record date, payment date and dividends paid per preferred share of, and per depositary share representing, the Series A Preferred Stock: Dividends Paid Declaration Date Record Date Payment Date Per Preferred Share Per Depositary Share Quarter Ended 03/31/2026 February 16, 2026 March 16, 2026 March 30, 2026 $ 500 $ 0.50 Quarter Ended 03/31/2025 February 17, 2025 March 11, 2025 March 31, 2025 $ 500 $ 0.50 Common Stock At March 31, 2026 and December 31, 2025, the Company was authorized to issue up to 1 billion shares of common stock with a par value of $ 0.01 per share. 77 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 19. Equity Shares Issued to TPG On February 11, 2026, Jackson Financial and TPG Inc. ("TPG") completed the transaction announced on January 6, 2026, resulting in TPG acquiring 4,715,554 shares of Jackson Financial common stock for $ 500 million. As a result, Jackson Financial re-issued treasury shares having an aggregate cost of $ 178 million and recognized a corresponding gain on re-issuance of treasury shares of $ 322 million, which was recorded to additional paid-in capital. The cost of re-issued shares is determined on a first-in, first-out basis. See Note 25 - Subsequent Events of the Notes to Consolidated Financial Statements in the Company’s 2025 Annual Report for further discussion on this transaction. Share Repurchase Program On September 18, 2025, our Board of Directors authorized an increase of $ 1 billion in our existing authorization to repurchase shares of our outstanding common stock as part of the Company's share repurchase program. As of April 28, 2026, the Company had remaining authorization to apply up to $ 753 million to the purchase of its common shares. The Company expects to repurchase common shares from time to time in the open market or in privately negotiated transactions. The timing, form and amount of the share repurchases under the program are at the discretion of management and will depend on a variety of factors, including funds available at the Company, other potential uses for such funds, market conditions, the Company's capital position, legal requirements and other factors. The repurchase program may be modified, extended or terminated by the Board at any time. It does not have an expiration date. There can be no assurance that we will continue share repurchases or approve any further increase to our current, or approve any new, stock repurchase program, or any assurance to the amount of any repurchases that may be made pursuant to such programs. Through March 31, 2026, we have incurred $ 10 million of excise tax in connection with share repurchases that exceeded stock issuances. The excise tax incurred was recognized as part of the cost basis of the treasury stock acquired and not reported as income tax expense. The following table represents share repurchase activities as part of our share repurchase program: Period Number of Shares Repurchased Total Payments (in millions) Average Price Paid Per Share 2025 (January 1- March 31) 1,966,909 $ 172 $ 87.69 2025 (April 1- June 30) 1,920,154 158 82.06 2025 (July 1- September 30) 1,636,094 154 94.32 2025 (October 1- December 31) 1,507,378 150 99.66 Total 2025 7,030,535 $ 634 $ 90.26 2026 (January 1- March 31) 1,714,620 192 111.87 2026 (April 1- April 28) 527,648 57 108.04 Total 2026 2,242,268 $ 249 $ 110.97 The following table presents changes in the number of shares of common stock outstanding: Common Stock Issued Treasury Stock Total Common Stock Outstanding Shares at December 31, 2025 94,488,315 ( 27,662,683 ) 66,825,632 Share-based compensation programs — 444,186 (1) 444,186 Shares repurchased under repurchase program — ( 1,714,620 ) ( 1,714,620 ) Common stock issued to TPG — 4,715,554 4,715,554 Shares at March 31, 2026 94,488,315 ( 24,217,563 ) 70,270,752 (1) Represents net shares issued from treasury stock pursuant to the Company’s share-based compensation programs. 78 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 19. Equity Dividends to Shareholders Any declaration of cash dividends on common stock will be at the discretion of JFI’s Board of Directors and will depend on our financial condition, earnings, liquidity and capital requirements, regulatory constraints, level of indebtedness, preferred stock, contractual restrictions with respect to paying cash dividends, restrictions imposed by Delaware law, general business conditions and any other factors that JFI’s Board of Directors deems relevant in making any such determination. Therefore, there can be no assurance that we will pay any cash dividends to holders of our stock or as to the amount of any such cash dividend. The following table presents declaration date, record date, payment date and dividends paid per share of JFI’s common stock: Declaration Date Record Date Payment Date Dividends Paid Per Share Quarter Ended 03/31/2026 February 16, 2026 March 16, 2026 March 26, 2026 $ 0.90 Quarter Ended 03/31/2025 February 17, 2025 March 11, 2025 March 20, 2025 $ 0.80 20. Earnings Per Share Basic earnings per share is calculated by dividing net income (loss) attributable to Jackson Financial common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the net income (loss) attributable to Jackson Financial common shareholders, by the weighted-average number of shares of common stock outstanding for the period, plus shares representing the dilutive effect of share-based awards. The Company grants share-based awards subject to vesting provisions of its 2021 Omnibus Incentive Plan, which can have a dilutive effect. See Note 18 - Share-Based Compensation of the Notes to Consolidated Financial Statements in the Company’s 2025 Annual Report for further description of our share-based awards. The following table sets forth the calculation of earnings per common share: Three Months Ended March 31, 2026 2025 (in millions, except share and per share data) Net income (loss) attributable to Jackson Financial Inc. $ ( 424 ) $ ( 24 ) Less: Preferred stock dividends 11 11 Net income (loss) attributable to Jackson Financial Inc. common shareholders $ ( 435 ) $ ( 35 ) Weighted average shares of common stock outstanding - basic 69,743,841 73,469,317 Dilutive common shares — — Weighted average shares of common stock outstanding - diluted (1) 69,743,841 73,469,317 Earnings per share—common stock Basic $ ( 6.24 ) $ ( 0.48 ) Diluted $ ( 6.24 ) $ ( 0.48 ) (1) If we reported a net loss attributable to Jackson Financial Inc., all common stock equivalents are anti-dilutive and are therefore excluded from the calculation of diluted shares and diluted per share amounts. The shares excluded from the diluted EPS calculation were 317,447 and 247,765 shares for the three months ended March 31, 2026 and 2025. 79 Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 21. Subsequent Events 21. Subsequent Events The Company has evaluated subsequent events through the date these Condensed Consolidated Financial Statements were issued. Dividends Declared to Shareholders On May 1, 2026, our Board of Directors approved a cash dividend on JFI's common stock of $ 0.90 per share for the second quarter 2026, payable on June 25, 2026, to common shareholders of record on June 11, 2026. The Company also announced the declaration of a cash dividend of $ 0.50 per depositary share, each representing a 1/1,000th interest in a share of Fixed-Rate Reset Noncumulative Perpetual Preferred Stock, Series A. The dividend will be payable on June 30, 2026, to depositary shareholders of record at the close of business on June 11, 2026. 80